BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1310176 O[C@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-13(14-7-12(23)8-15(24)19(14)27-18)5-6-17(29)26-20-16(28)9-25-21(20)30/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) CTXLPYZCBOVVQK-UHFFFAOYSA-N 50547875 CHEMBL4754532::US20230271945, Compound 1 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50547875 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50547875&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620015 461678215 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310177 O[C@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-13(14-7-12(23)8-15(24)19(14)27-18)5-6-17(29)26-20-16(28)9-25-21(20)30/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) CTXLPYZCBOVVQK-UHFFFAOYSA-N 50547875 CHEMBL4754532::US20230271945, Compound 1 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50547875 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50547875&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620015 461678215 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310178 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-13(14-7-12(23)8-15(24)19(14)27-18)5-6-17(29)26-20-16(28)9-25-21(20)30/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) CTXLPYZCBOVVQK-UHFFFAOYSA-N 615085 US20230271945, Compound 2::3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (2)::US20230271945, Compound 88::US20230271945, Compound 89 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615085&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147289591 484204381 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310179 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-13(14-7-12(23)8-15(24)19(14)27-18)5-6-17(29)26-20-16(28)9-25-21(20)30/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) CTXLPYZCBOVVQK-UHFFFAOYSA-N 615085 US20230271945, Compound 2::3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (2)::US20230271945, Compound 88::US20230271945, Compound 89 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615085&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147289591 484204381 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310180 Fc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H18F3N3O2/c22-12-3-1-11(2-4-12)19-14(15-9-13(23)10-16(24)20(15)27-19)5-6-18(28)26-17-7-8-25-21(17)29/h1-4,9-10,17,27H,5-8H2,(H,25,29)(H,26,28) XXHTXOAUVHFTLP-UHFFFAOYSA-N 615086 3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S)-2-oxopyrrolidin-3-yl]propanamide (3)::US20230271945, Compound 3 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615086&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 152470468 484204382 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310181 Fc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H18F3N3O2/c22-12-3-1-11(2-4-12)19-14(15-9-13(23)10-16(24)20(15)27-19)5-6-18(28)26-17-7-8-25-21(17)29/h1-4,9-10,17,27H,5-8H2,(H,25,29)(H,26,28) XXHTXOAUVHFTLP-UHFFFAOYSA-N 615086 3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S)-2-oxopyrrolidin-3-yl]propanamide (3)::US20230271945, Compound 3 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615086&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 152470468 484204382 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310182 CC(=O)O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C23H20F3N3O4/c1-11(30)33-18-10-27-23(32)22(18)28-19(31)7-6-15-16-8-14(25)9-17(26)21(16)29-20(15)12-2-4-13(24)5-3-12/h2-5,8-9,18,22,29H,6-7,10H2,1H3,(H,27,32)(H,28,31) KRJBFNIEKCCEIZ-UHFFFAOYSA-N 615087 [(3R,4S)-4-[3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]propanoylamino]-5-oxo-pyrrolidin-3-yl]acetate (4)::US20230271945, Compound 4 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615087&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148259566 484204383 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310183 Fc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1CC(=O)NC1=O |r| InChI=1S/C21H16F3N3O3/c22-11-3-1-10(2-4-11)19-13(14-7-12(23)8-15(24)20(14)27-19)5-6-17(28)25-16-9-18(29)26-21(16)30/h1-4,7-8,16,27H,5-6,9H2,(H,25,28)(H,26,29,30) QAWRGWPULAFBNW-UHFFFAOYSA-N 615088 US20230271945, Compound 5 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615088&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620070 484204384 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310184 Fc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1CC(=O)NC1=O |r| InChI=1S/C21H16F3N3O3/c22-11-3-1-10(2-4-11)19-13(14-7-12(23)8-15(24)20(14)27-19)5-6-17(28)25-16-9-18(29)26-21(16)30/h1-4,7-8,16,27H,5-6,9H2,(H,25,28)(H,26,29,30) QAWRGWPULAFBNW-UHFFFAOYSA-N 615088 US20230271945, Compound 5 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615088&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620070 484204384 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310185 CC1C[C@H](NC(=O)CCc2c([nH]c3c(F)cc(F)cc23)-c2ccc(F)cc2)C(=O)N1 |r,w:1.0| InChI=1S/C22H20F3N3O2/c1-11-8-18(22(30)26-11)27-19(29)7-6-15-16-9-14(24)10-17(25)21(16)28-20(15)12-2-4-13(23)5-3-12/h2-5,9-11,18,28H,6-8H2,1H3,(H,26,30)(H,27,29) QBFVZNNJGSSGKS-UHFFFAOYSA-N 615089 US20230271945, Compound 6 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615089&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620016 484204385 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310186 CC1C[C@H](NC(=O)CCc2c([nH]c3c(F)cc(F)cc23)-c2ccc(F)cc2)C(=O)N1 |r,w:1.0| InChI=1S/C22H20F3N3O2/c1-11-8-18(22(30)26-11)27-19(29)7-6-15-16-9-14(24)10-17(25)21(16)28-20(15)12-2-4-13(23)5-3-12/h2-5,9-11,18,28H,6-8H2,1H3,(H,26,30)(H,27,29) QBFVZNNJGSSGKS-UHFFFAOYSA-N 615089 US20230271945, Compound 6 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615089&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620016 484204385 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310187 OC[C@@H]1C[C@H](NC(=O)CCc2c([nH]c3c(F)cc(F)cc23)-c2ccc(F)cc2)C(=O)N1 |r| InChI=1S/C22H20F3N3O3/c23-12-3-1-11(2-4-12)20-15(16-7-13(24)8-17(25)21(16)28-20)5-6-19(30)27-18-9-14(10-29)26-22(18)31/h1-4,7-8,14,18,28-29H,5-6,9-10H2,(H,26,31)(H,27,30) QHZOFIIZYHESTA-UHFFFAOYSA-N 615090 US20230271945, Compound 7 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615090&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620115 484204386 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310188 OC[C@@H]1C[C@H](NC(=O)CCc2c([nH]c3c(F)cc(F)cc23)-c2ccc(F)cc2)C(=O)N1 |r| InChI=1S/C22H20F3N3O3/c23-12-3-1-11(2-4-12)20-15(16-7-13(24)8-17(25)21(16)28-20)5-6-19(30)27-18-9-14(10-29)26-22(18)31/h1-4,7-8,14,18,28-29H,5-6,9-10H2,(H,26,31)(H,27,30) QHZOFIIZYHESTA-UHFFFAOYSA-N 615090 US20230271945, Compound 7 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615090&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620115 484204386 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310189 OC[C@H]1C[C@H](NC(=O)CCc2c([nH]c3c(F)cc(F)cc23)-c2ccc(F)cc2)C(=O)N1 |r| InChI=1S/C22H20F3N3O3/c23-12-3-1-11(2-4-12)20-15(16-7-13(24)8-17(25)21(16)28-20)5-6-19(30)27-18-9-14(10-29)26-22(18)31/h1-4,7-8,14,18,28-29H,5-6,9-10H2,(H,26,31)(H,27,30) QHZOFIIZYHESTA-UHFFFAOYSA-N 615091 US20230271945, Compound 8 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615091&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961055 484204387 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310190 OC[C@H]1C[C@H](NC(=O)CCc2c([nH]c3c(F)cc(F)cc23)-c2ccc(F)cc2)C(=O)N1 |r| InChI=1S/C22H20F3N3O3/c23-12-3-1-11(2-4-12)20-15(16-7-13(24)8-17(25)21(16)28-20)5-6-19(30)27-18-9-14(10-29)26-22(18)31/h1-4,7-8,14,18,28-29H,5-6,9-10H2,(H,26,31)(H,27,30) QHZOFIIZYHESTA-UHFFFAOYSA-N 615091 US20230271945, Compound 8 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615091&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961055 484204387 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310191 FC[C@@H]1C[C@H](NC(=O)CCc2c([nH]c3c(F)cc(F)cc23)-c2ccc(F)cc2)C(=O)N1 |r| InChI=1S/C22H19F4N3O2/c23-10-14-9-18(22(31)27-14)28-19(30)6-5-15-16-7-13(25)8-17(26)21(16)29-20(15)11-1-3-12(24)4-2-11/h1-4,7-8,14,18,29H,5-6,9-10H2,(H,27,31)(H,28,30) MDYJMFFDXNPLQD-UHFFFAOYSA-N 615092 US20230271945, Compound 9 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615092&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148465545 484204388 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310192 FC[C@H]1C[C@H](NC(=O)CCc2c([nH]c3c(F)cc(F)cc23)-c2ccc(F)cc2)C(=O)N1 |r| InChI=1S/C22H19F4N3O2/c23-10-14-9-18(22(31)27-14)28-19(30)6-5-15-16-7-13(25)8-17(26)21(16)29-20(15)11-1-3-12(24)4-2-11/h1-4,7-8,14,18,29H,5-6,9-10H2,(H,27,31)(H,28,30) MDYJMFFDXNPLQD-UHFFFAOYSA-N 615093 US20230271945, Compound 10 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615093&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148465544 484204389 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310193 C[C@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C22H20F3N3O2/c1-11-10-26-22(30)19(11)27-18(29)7-6-15-16-8-14(24)9-17(25)21(16)28-20(15)12-2-4-13(23)5-3-12/h2-5,8-9,11,19,28H,6-7,10H2,1H3,(H,26,30)(H,27,29) JKLVAXZSPYTWKK-UHFFFAOYSA-N 615094 US20230271945, Compound 11 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615094&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148073050 484204390 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310194 O[C@H]1CNC(=O)[C@@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-13(14-7-12(23)8-15(24)19(14)27-18)5-6-17(29)26-20-16(28)9-25-21(20)30/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) CTXLPYZCBOVVQK-UHFFFAOYSA-N 615095 US20230271945, Compound 12 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615095&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147289590 484204391 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310195 Fc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@@H]1CCNC1=O |r| InChI=1S/C21H18F3N3O2/c22-12-3-1-11(2-4-12)19-14(15-9-13(23)10-16(24)20(15)27-19)5-6-18(28)26-17-7-8-25-21(17)29/h1-4,9-10,17,27H,5-8H2,(H,25,29)(H,26,28) XXHTXOAUVHFTLP-UHFFFAOYSA-N 615096 US20230271945, Compound 13 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615096&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620022 484204392 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310196 Fc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@@H]1CCNC1=O |r| InChI=1S/C21H18F3N3O2/c22-12-3-1-11(2-4-12)19-14(15-9-13(23)10-16(24)20(15)27-19)5-6-18(28)26-17-7-8-25-21(17)29/h1-4,9-10,17,27H,5-8H2,(H,25,29)(H,26,28) XXHTXOAUVHFTLP-UHFFFAOYSA-N 615096 US20230271945, Compound 13 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615096&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620022 484204392 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310197 CC1(CCNC1=O)NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |w:1.0| InChI=1S/C22H20F3N3O2/c1-22(8-9-26-21(22)30)28-18(29)7-6-15-16-10-14(24)11-17(25)20(16)27-19(15)12-2-4-13(23)5-3-12/h2-5,10-11,27H,6-9H2,1H3,(H,26,30)(H,28,29) NSXDPNXCAPXYNA-UHFFFAOYSA-N 615097 US20230271945, Compound 14 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615097&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619947 484204393 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310198 CC1(CCNC1=O)NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |w:1.0| InChI=1S/C22H20F3N3O2/c1-22(8-9-26-21(22)30)28-18(29)7-6-15-16-10-14(24)11-17(25)20(16)27-19(15)12-2-4-13(23)5-3-12/h2-5,10-11,27H,6-9H2,1H3,(H,26,30)(H,28,29) NSXDPNXCAPXYNA-UHFFFAOYSA-N 615097 US20230271945, Compound 14 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615097&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619947 484204393 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310199 O[C@@H]1CNC(=O)[C@@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-13(14-7-12(23)8-15(24)19(14)27-18)5-6-17(29)26-20-16(28)9-25-21(20)30/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) CTXLPYZCBOVVQK-UHFFFAOYSA-N 615098 US20230271945, Compound 15 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615098&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154941552 484204394 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310200 Fc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@@H]1CC(=O)NC1=O |r| InChI=1S/C21H16F3N3O3/c22-11-3-1-10(2-4-11)19-13(14-7-12(23)8-15(24)20(14)27-19)5-6-17(28)25-16-9-18(29)26-21(16)30/h1-4,7-8,16,27H,5-6,9H2,(H,25,28)(H,26,29,30) QAWRGWPULAFBNW-UHFFFAOYSA-N 615099 US20230271945, Compound 16 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615099&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961662 484204395 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310201 Fc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@@H]1CC(=O)NC1=O |r| InChI=1S/C21H16F3N3O3/c22-11-3-1-10(2-4-11)19-13(14-7-12(23)8-15(24)20(14)27-19)5-6-17(28)25-16-9-18(29)26-21(16)30/h1-4,7-8,16,27H,5-6,9H2,(H,25,28)(H,26,29,30) QAWRGWPULAFBNW-UHFFFAOYSA-N 615099 US20230271945, Compound 16 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615099&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961662 484204395 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310202 Fc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)NC1CC2(CC2)NC1=O InChI=1S/C23H20F3N3O2/c24-13-3-1-12(2-4-13)20-15(16-9-14(25)10-17(26)21(16)28-20)5-6-19(30)27-18-11-23(7-8-23)29-22(18)31/h1-4,9-10,18,28H,5-8,11H2,(H,27,30)(H,29,31) XCESMVPJDIACBF-UHFFFAOYSA-N 615100 US20230271945, Compound 17 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615100&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620100 484204396 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310203 Fc1cc(F)c2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(cc1)C#N |r| InChI=1S/C22H18F2N4O2/c23-14-9-16-15(5-6-19(29)27-18-7-8-26-22(18)30)20(28-21(16)17(24)10-14)13-3-1-12(11-25)2-4-13/h1-4,9-10,18,28H,5-8H2,(H,26,30)(H,27,29) WJPMVVYPNLGJLY-UHFFFAOYSA-N 50547876 CHEMBL4791770::US20230271945, Compound 20 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50547876 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50547876&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 152272452 461678216 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310204 Fc1cc(F)c2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(cc1)C#N |r| InChI=1S/C22H18F2N4O2/c23-14-9-16-15(5-6-19(29)27-18-7-8-26-22(18)30)20(28-21(16)17(24)10-14)13-3-1-12(11-25)2-4-13/h1-4,9-10,18,28H,5-8H2,(H,26,30)(H,27,29) WJPMVVYPNLGJLY-UHFFFAOYSA-N 50547876 CHEMBL4791770::US20230271945, Compound 20 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50547876 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50547876&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 152272452 461678216 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310205 FC(F)Oc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C22H19F4N3O3/c23-12-9-15-14(5-6-18(30)28-17-7-8-27-21(17)31)19(29-20(15)16(24)10-12)11-1-3-13(4-2-11)32-22(25)26/h1-4,9-10,17,22,29H,5-8H2,(H,27,31)(H,28,30) DEAZMFKHTBYOFZ-UHFFFAOYSA-N 615102 US20230271945, Compound 21 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615102&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620105 484204398 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310206 FC(F)Oc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C22H19F4N3O3/c23-12-9-15-14(5-6-18(30)28-17-7-8-27-21(17)31)19(29-20(15)16(24)10-12)11-1-3-13(4-2-11)32-22(25)26/h1-4,9-10,17,22,29H,5-8H2,(H,27,31)(H,28,30) DEAZMFKHTBYOFZ-UHFFFAOYSA-N 615102 US20230271945, Compound 21 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615102&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620105 484204398 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310207 Cc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C22H21F2N3O3/c1-11-2-4-12(5-3-11)19-14(15-8-13(23)9-16(24)20(15)27-19)6-7-18(29)26-21-17(28)10-25-22(21)30/h2-5,8-9,17,21,27-28H,6-7,10H2,1H3,(H,25,30)(H,26,29) RCHIFIDWVHTOFW-UHFFFAOYSA-N 615103 US20230271945, Compound 22 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615103&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961124 484204399 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310208 Cc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C22H21F2N3O2/c1-12-2-4-13(5-3-12)20-15(16-10-14(23)11-17(24)21(16)27-20)6-7-19(28)26-18-8-9-25-22(18)29/h2-5,10-11,18,27H,6-9H2,1H3,(H,25,29)(H,26,28) PKXTUYUIPYXUEP-UHFFFAOYSA-N 615104 US20230271945, Compound 23 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615104&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620150 484204400 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310209 Cc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@@H]1CCNC1=O |r| InChI=1S/C22H21F2N3O2/c1-12-2-4-13(5-3-12)20-15(16-10-14(23)11-17(24)21(16)27-20)6-7-19(28)26-18-8-9-25-22(18)29/h2-5,10-11,18,27H,6-9H2,1H3,(H,25,29)(H,26,28) PKXTUYUIPYXUEP-UHFFFAOYSA-N 615105 US20230271945, Compound 24 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615105&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148925630 484204401 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310210 Fc1cc(F)c2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccccc1 |r| InChI=1S/C21H19F2N3O2/c22-13-10-15-14(6-7-18(27)25-17-8-9-24-21(17)28)19(12-4-2-1-3-5-12)26-20(15)16(23)11-13/h1-5,10-11,17,26H,6-9H2,(H,24,28)(H,25,27) ZAESTKVBSLOHJM-UHFFFAOYSA-N 615106 US20230271945, Compound 25 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615106&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620166 484204402 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310211 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccccc1 |r| InChI=1S/C21H19F2N3O3/c22-12-8-14-13(6-7-17(28)25-20-16(27)10-24-21(20)29)18(11-4-2-1-3-5-11)26-19(14)15(23)9-12/h1-5,8-9,16,20,26-27H,6-7,10H2,(H,24,29)(H,25,28) FNBUPPVNGVGPNL-UHFFFAOYSA-N 615107 US20230271945, Compound 26 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615107&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961130 484204403 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310212 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccccc1 |r| InChI=1S/C21H19F2N3O3/c22-12-8-14-13(6-7-17(28)25-20-16(27)10-24-21(20)29)18(11-4-2-1-3-5-11)26-19(14)15(23)9-12/h1-5,8-9,16,20,26-27H,6-7,10H2,(H,24,29)(H,25,28) FNBUPPVNGVGPNL-UHFFFAOYSA-N 615107 US20230271945, Compound 26 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615107&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961130 484204403 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310213 Fc1ccc(cc1)-c1[nH]c2c(F)cc(Br)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H18BrF2N3O2/c22-12-9-15-14(5-6-18(28)26-17-7-8-25-21(17)29)19(27-20(15)16(24)10-12)11-1-3-13(23)4-2-11/h1-4,9-10,17,27H,5-8H2,(H,25,29)(H,26,28) CIXJZBHERFIZKB-UHFFFAOYSA-N 615108 US20230271945, Compound 27 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615108&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147231009 484204404 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310214 Fc1ccc(cc1)-c1[nH]c2c(F)cc(Br)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H18BrF2N3O2/c22-12-9-15-14(5-6-18(28)26-17-7-8-25-21(17)29)19(27-20(15)16(24)10-12)11-1-3-13(23)4-2-11/h1-4,9-10,17,27H,5-8H2,(H,25,29)(H,26,28) CIXJZBHERFIZKB-UHFFFAOYSA-N 615108 US20230271945, Compound 27 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615108&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147231009 484204404 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310215 Fc1ccc(cc1)-c1[nH]c2c(F)cc(cc2c1CCC(=O)N[C@H]1CCNC1=O)C#N |r| InChI=1S/C22H18F2N4O2/c23-14-3-1-13(2-4-14)20-15(5-6-19(29)27-18-7-8-26-22(18)30)16-9-12(11-25)10-17(24)21(16)28-20/h1-4,9-10,18,28H,5-8H2,(H,26,30)(H,27,29) MMULHZUGSIJOPV-UHFFFAOYSA-N 615109 US20230271945, Compound 28 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615109&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148512581 484204405 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310216 Fc1ccc(cc1)-c1[nH]c2c(F)cc(cc2c1CCC(=O)N[C@H]1CCNC1=O)C#N |r| InChI=1S/C22H18F2N4O2/c23-14-3-1-13(2-4-14)20-15(5-6-19(29)27-18-7-8-26-22(18)30)16-9-12(11-25)10-17(24)21(16)28-20/h1-4,9-10,18,28H,5-8H2,(H,26,30)(H,27,29) MMULHZUGSIJOPV-UHFFFAOYSA-N 615109 US20230271945, Compound 28 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615109&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148512581 484204405 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310217 Cc1cc(F)c2[nH]c(c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c2c1)-c1ccc(F)cc1 |r| InChI=1S/C22H21F2N3O3/c1-11-8-15-14(6-7-18(29)26-21-17(28)10-25-22(21)30)19(27-20(15)16(24)9-11)12-2-4-13(23)5-3-12/h2-5,8-9,17,21,27-28H,6-7,10H2,1H3,(H,25,30)(H,26,29) QJYGUADZIWEYTL-UHFFFAOYSA-N 615110 US20230271945, Compound 29 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615110&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620110 484204406 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310218 Cc1cc(F)c2[nH]c(c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c2c1)-c1ccc(F)cc1 |r| InChI=1S/C22H21F2N3O3/c1-11-8-15-14(6-7-18(29)26-21-17(28)10-25-22(21)30)19(27-20(15)16(24)9-11)12-2-4-13(23)5-3-12/h2-5,8-9,17,21,27-28H,6-7,10H2,1H3,(H,25,30)(H,26,29) QJYGUADZIWEYTL-UHFFFAOYSA-N 615110 US20230271945, Compound 29 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615110&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620110 484204406 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310219 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(Cl)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18ClF2N3O3/c22-11-7-14-13(5-6-17(29)26-20-16(28)9-25-21(20)30)18(27-19(14)15(24)8-11)10-1-3-12(23)4-2-10/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) DGQKTGOFSPPBCP-UHFFFAOYSA-N 615111 US20230271945, Compound 30 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615111&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147357754 484204407 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310220 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(Cl)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18ClF2N3O3/c22-11-7-14-13(5-6-17(29)26-20-16(28)9-25-21(20)30)18(27-19(14)15(24)8-11)10-1-3-12(23)4-2-10/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) DGQKTGOFSPPBCP-UHFFFAOYSA-N 615111 US20230271945, Compound 30 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615111&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147357754 484204407 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310221 Cc1cc(F)c2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(F)cc1 |r| InChI=1S/C22H21F2N3O2/c1-12-10-16-15(6-7-19(28)26-18-8-9-25-22(18)29)20(27-21(16)17(24)11-12)13-2-4-14(23)5-3-13/h2-5,10-11,18,27H,6-9H2,1H3,(H,25,29)(H,26,28) FSPJLZBPIRWANM-UHFFFAOYSA-N 615112 US20230271945, Compound 31 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615112&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620078 484204408 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310222 Fc1ccc(cc1)-c1[nH]c2c(F)cc(Cl)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H18ClF2N3O2/c22-12-9-15-14(5-6-18(28)26-17-7-8-25-21(17)29)19(27-20(15)16(24)10-12)11-1-3-13(23)4-2-11/h1-4,9-10,17,27H,5-8H2,(H,25,29)(H,26,28) FCUQQHJZRQGYQD-UHFFFAOYSA-N 615113 US20230271945, Compound 32 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615113&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619959 484204409 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310223 Fc1ccc(cc1)-c1[nH]c2c(F)cc(Cl)cc2c1CCC(=O)N[C@@H]1CCNC1=O |r| InChI=1S/C21H18ClF2N3O2/c22-12-9-15-14(5-6-18(28)26-17-7-8-25-21(17)29)19(27-20(15)16(24)10-12)11-1-3-13(23)4-2-11/h1-4,9-10,17,27H,5-8H2,(H,25,29)(H,26,28) FCUQQHJZRQGYQD-UHFFFAOYSA-N 615114 US20230271945, Compound 33 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615114&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620107 484204410 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310224 Fc1ccc(cc1)-c1[nH]c2c(Cl)cc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H18ClF2N3O2/c22-16-10-13(24)9-15-14(5-6-18(28)26-17-7-8-25-21(17)29)19(27-20(15)16)11-1-3-12(23)4-2-11/h1-4,9-10,17,27H,5-8H2,(H,25,29)(H,26,28) VDVYBXDBBCXVAE-UHFFFAOYSA-N 615115 US20230271945, Compound 34 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615115&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620104 484204411 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310225 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Cl)cc(F)cc12)-c1ccccc1 |r| InChI=1S/C21H19ClFN3O3/c22-15-9-12(23)8-14-13(18(26-19(14)15)11-4-2-1-3-5-11)6-7-17(28)25-20-16(27)10-24-21(20)29/h1-5,8-9,16,20,26-27H,6-7,10H2,(H,24,29)(H,25,28) ZMLSQICBMNOFHL-UHFFFAOYSA-N 615116 US20230271945, Compound 35 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615116&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620088 484204412 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310226 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Cl)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18ClF2N3O3/c22-15-8-12(24)7-14-13(5-6-17(29)26-20-16(28)9-25-21(20)30)18(27-19(14)15)10-1-3-11(23)4-2-10/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) FWCNMWUYPJHYAC-UHFFFAOYSA-N 615117 US20230271945, Compound 36 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615117&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147579411 484204413 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310227 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Cl)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18ClF2N3O3/c22-15-8-12(24)7-14-13(5-6-17(29)26-20-16(28)9-25-21(20)30)18(27-19(14)15)10-1-3-11(23)4-2-10/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) FWCNMWUYPJHYAC-UHFFFAOYSA-N 615117 US20230271945, Compound 36 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615117&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147579411 484204413 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310228 Cc1cc(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| InChI=1S/C22H21F2N3O3/c1-11-8-14(24)9-16-15(6-7-18(29)26-21-17(28)10-25-22(21)30)20(27-19(11)16)12-2-4-13(23)5-3-12/h2-5,8-9,17,21,27-28H,6-7,10H2,1H3,(H,25,30)(H,26,29) IATWLLUECXTICE-UHFFFAOYSA-N 615118 US20230271945, Compound 37 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615118&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961008 484204414 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310229 Cc1cc(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| InChI=1S/C22H21F2N3O3/c1-11-8-14(24)9-16-15(6-7-18(29)26-21-17(28)10-25-22(21)30)20(27-19(11)16)12-2-4-13(23)5-3-12/h2-5,8-9,17,21,27-28H,6-7,10H2,1H3,(H,25,30)(H,26,29) IATWLLUECXTICE-UHFFFAOYSA-N 615118 US20230271945, Compound 37 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615118&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961008 484204414 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310230 Cc1cc(F)cc2c(CCC(=O)N[C@H]3CCNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| InChI=1S/C22H21F2N3O2/c1-12-10-15(24)11-17-16(6-7-19(28)26-18-8-9-25-22(18)29)21(27-20(12)17)13-2-4-14(23)5-3-13/h2-5,10-11,18,27H,6-9H2,1H3,(H,25,29)(H,26,28) HIKWOAIVYLEIQU-UHFFFAOYSA-N 615119 US20230271945, Compound 38::US20230271945, Compound 39 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615119&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620035 484204415 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310231 Cc1cc(F)cc2c(CCC(=O)N[C@H]3CCNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| InChI=1S/C22H21F2N3O2/c1-12-10-15(24)11-17-16(6-7-19(28)26-18-8-9-25-22(18)29)21(27-20(12)17)13-2-4-14(23)5-3-13/h2-5,10-11,18,27H,6-9H2,1H3,(H,25,29)(H,26,28) HIKWOAIVYLEIQU-UHFFFAOYSA-N 615119 US20230271945, Compound 38::US20230271945, Compound 39 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615119&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620035 484204415 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310232 COc1cc(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| InChI=1S/C22H21F2N3O4/c1-31-17-9-13(24)8-15-14(6-7-18(29)26-21-16(28)10-25-22(21)30)19(27-20(15)17)11-2-4-12(23)5-3-11/h2-5,8-9,16,21,27-28H,6-7,10H2,1H3,(H,25,30)(H,26,29) FXENNTAEOGGJLZ-UHFFFAOYSA-N 615121 US20230271945, Compound 40 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615121&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620002 484204416 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310233 COc1cc(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| InChI=1S/C22H21F2N3O4/c1-31-17-9-13(24)8-15-14(6-7-18(29)26-21-16(28)10-25-22(21)30)19(27-20(15)17)11-2-4-12(23)5-3-11/h2-5,8-9,16,21,27-28H,6-7,10H2,1H3,(H,25,30)(H,26,29) FXENNTAEOGGJLZ-UHFFFAOYSA-N 615121 US20230271945, Compound 40 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615121&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620002 484204416 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310234 COc1cc(F)cc2c(CCC(=O)N[C@H]3CCNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| InChI=1S/C22H21F2N3O3/c1-30-18-11-14(24)10-16-15(6-7-19(28)26-17-8-9-25-22(17)29)20(27-21(16)18)12-2-4-13(23)5-3-12/h2-5,10-11,17,27H,6-9H2,1H3,(H,25,29)(H,26,28) UHANLPBHIVQPKB-UHFFFAOYSA-N 615122 US20230271945, Compound 41 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615122 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615122&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620061 484204417 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310235 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cc(F)cc12)C#N)-c1ccc(F)cc1 |r| InChI=1S/C22H18F2N4O3/c23-13-3-1-11(2-4-13)19-15(16-8-14(24)7-12(9-25)20(16)28-19)5-6-18(30)27-21-17(29)10-26-22(21)31/h1-4,7-8,17,21,28-29H,5-6,10H2,(H,26,31)(H,27,30) XRNSULQUZIZBGE-UHFFFAOYSA-N 50547877 CHEMBL4795347::US20230271945, Compound 42 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50547877 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50547877&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961202 461678217 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310236 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cc(F)cc12)C#N)-c1ccc(F)cc1 |r| InChI=1S/C22H18F2N4O3/c23-13-3-1-11(2-4-13)19-15(16-8-14(24)7-12(9-25)20(16)28-19)5-6-18(30)27-21-17(29)10-26-22(21)31/h1-4,7-8,17,21,28-29H,5-6,10H2,(H,26,31)(H,27,30) XRNSULQUZIZBGE-UHFFFAOYSA-N 50547877 CHEMBL4795347::US20230271945, Compound 42 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50547877 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50547877&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961202 461678217 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310237 Cc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(Br)cc1 |r| InChI=1S/C22H22BrN3O2/c1-13-2-8-18-17(12-13)16(21(26-18)14-3-5-15(23)6-4-14)7-9-20(27)25-19-10-11-24-22(19)28/h2-6,8,12,19,26H,7,9-11H2,1H3,(H,24,28)(H,25,27) UOUKGCFYJSFPGH-UHFFFAOYSA-N 615124 3-[2-(4-bromophenyl)-5-methyl-1H-indol-3-yl]-N-[(3S)-2-oxopyrrolidin-3-yl]propanamide (43)::US20230271945, Compound 43 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615124&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620077 484204419 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310238 Cc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(Br)cc1 |r| InChI=1S/C22H22BrN3O2/c1-13-2-8-18-17(12-13)16(21(26-18)14-3-5-15(23)6-4-14)7-9-20(27)25-19-10-11-24-22(19)28/h2-6,8,12,19,26H,7,9-11H2,1H3,(H,24,28)(H,25,27) UOUKGCFYJSFPGH-UHFFFAOYSA-N 615124 3-[2-(4-bromophenyl)-5-methyl-1H-indol-3-yl]-N-[(3S)-2-oxopyrrolidin-3-yl]propanamide (43)::US20230271945, Compound 43 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615124&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620077 484204419 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310239 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(Cl)cc12)-c1ccccc1 |r| InChI=1S/C21H20ClN3O3/c22-13-6-8-16-15(10-13)14(19(24-16)12-4-2-1-3-5-12)7-9-18(27)25-20-17(26)11-23-21(20)28/h1-6,8,10,17,20,24,26H,7,9,11H2,(H,23,28)(H,25,27) HVUHSZQZLOLGJS-UHFFFAOYSA-N 615125 3-(5-chloro-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (44)::US20230271945, Compound 44 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615125&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147856232 484204420 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310240 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(Cl)cc12)-c1ccccc1 |r| InChI=1S/C21H20ClN3O3/c22-13-6-8-16-15(10-13)14(19(24-16)12-4-2-1-3-5-12)7-9-18(27)25-20-17(26)11-23-21(20)28/h1-6,8,10,17,20,24,26H,7,9,11H2,(H,23,28)(H,25,27) HVUHSZQZLOLGJS-UHFFFAOYSA-N 615125 3-(5-chloro-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (44)::US20230271945, Compound 44 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615125&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147856232 484204420 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310241 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(Cl)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H19ClFN3O3/c22-12-3-7-16-15(9-12)14(19(25-16)11-1-4-13(23)5-2-11)6-8-18(28)26-20-17(27)10-24-21(20)29/h1-5,7,9,17,20,25,27H,6,8,10H2,(H,24,29)(H,26,28) RPWGHTMHWUKCPK-UHFFFAOYSA-N 615126 3-[5-chloro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (45)::US20230271945, Compound 45 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615126&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 152782910 484204421 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310242 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H19F2N3O3/c22-12-3-1-11(2-4-12)19-14(15-9-13(23)5-7-16(15)25-19)6-8-18(28)26-20-17(27)10-24-21(20)29/h1-5,7,9,17,20,25,27H,6,8,10H2,(H,24,29)(H,26,28) PNQZQMMGXABQOL-UHFFFAOYSA-N 615127 US20230271945, Compound 46 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615127&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148939757 484204422 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310243 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H19F2N3O3/c22-12-3-1-11(2-4-12)19-14(15-9-13(23)5-7-16(15)25-19)6-8-18(28)26-20-17(27)10-24-21(20)29/h1-5,7,9,17,20,25,27H,6,8,10H2,(H,24,29)(H,26,28) PNQZQMMGXABQOL-UHFFFAOYSA-N 615127 US20230271945, Compound 46 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615127&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148939757 484204422 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310244 Fc1ccc(cc1)-c1[nH]c2ccc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H19F2N3O2/c22-13-3-1-12(2-4-13)20-15(16-11-14(23)5-7-17(16)26-20)6-8-19(27)25-18-9-10-24-21(18)28/h1-5,7,11,18,26H,6,8-10H2,(H,24,28)(H,25,27) LWHBTAZNEXDNMN-UHFFFAOYSA-N 615128 US20230271945, Compound 47 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615128&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148424704 484204423 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310245 Fc1ccc(cc1)-c1[nH]c2ccc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H19F2N3O2/c22-13-3-1-12(2-4-13)20-15(16-11-14(23)5-7-17(16)26-20)6-8-19(27)25-18-9-10-24-21(18)28/h1-5,7,11,18,26H,6,8-10H2,(H,24,28)(H,25,27) LWHBTAZNEXDNMN-UHFFFAOYSA-N 615128 US20230271945, Compound 47 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615128&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148424704 484204423 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310246 Fc1ccc(cc1)-c1[nH]c2ccc(F)cc2c1CCC(=O)NC1CCNC1=O |w:21.24| InChI=1S/C21H19F2N3O2/c22-13-3-1-12(2-4-13)20-15(16-11-14(23)5-7-17(16)26-20)6-8-19(27)25-18-9-10-24-21(18)28/h1-5,7,11,18,26H,6,8-10H2,(H,24,28)(H,25,27) LWHBTAZNEXDNMN-UHFFFAOYSA-N 615129 US20230271945, Compound 48 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615129&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620149 484204424 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310247 Fc1ccc(cc1)-c1[nH]c2ccc(F)cc2c1CCC(=O)NC1CCNC1=O |w:21.24| InChI=1S/C21H19F2N3O2/c22-13-3-1-12(2-4-13)20-15(16-11-14(23)5-7-17(16)26-20)6-8-19(27)25-18-9-10-24-21(18)28/h1-5,7,11,18,26H,6,8-10H2,(H,24,28)(H,25,27) LWHBTAZNEXDNMN-UHFFFAOYSA-N 615129 US20230271945, Compound 48 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615129&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620149 484204424 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310248 Fc1ccc(cc1)-c1[nH]c2ccc(F)cc2c1CCC(=O)N[C@@H]1CCNC1=O |r| InChI=1S/C21H19F2N3O2/c22-13-3-1-12(2-4-13)20-15(16-11-14(23)5-7-17(16)26-20)6-8-19(27)25-18-9-10-24-21(18)28/h1-5,7,11,18,26H,6,8-10H2,(H,24,28)(H,25,27) LWHBTAZNEXDNMN-UHFFFAOYSA-N 615130 US20230271945, Compound 49 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615130&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961177 484204425 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310249 Fc1ccc(cc1)-c1[nH]c2ccc(F)cc2c1CCC(=O)N[C@@H]1CCNC1=O |r| InChI=1S/C21H19F2N3O2/c22-13-3-1-12(2-4-13)20-15(16-11-14(23)5-7-17(16)26-20)6-8-19(27)25-18-9-10-24-21(18)28/h1-5,7,11,18,26H,6,8-10H2,(H,24,28)(H,25,27) LWHBTAZNEXDNMN-UHFFFAOYSA-N 615130 US20230271945, Compound 49 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615130&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961177 484204425 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310250 CN(C1CCNC1=O)C(=O)CCc1c([nH]c2ccc(F)cc12)-c1ccc(F)cc1 InChI=1S/C22H21F2N3O2/c1-27(19-10-11-25-22(19)29)20(28)9-7-16-17-12-15(24)6-8-18(17)26-21(16)13-2-4-14(23)5-3-13/h2-6,8,12,19,26H,7,9-11H2,1H3,(H,25,29) VSELNYTZBKEQRN-UHFFFAOYSA-N 615131 US20230271945, Compound 50 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615131&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153106996 484204426 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310251 CN(C1CCNC1=O)C(=O)CCc1c([nH]c2ccc(F)cc12)-c1ccc(F)cc1 InChI=1S/C22H21F2N3O2/c1-27(19-10-11-25-22(19)29)20(28)9-7-16-17-12-15(24)6-8-18(17)26-21(16)13-2-4-14(23)5-3-13/h2-6,8,12,19,26H,7,9-11H2,1H3,(H,25,29) VSELNYTZBKEQRN-UHFFFAOYSA-N 615131 US20230271945, Compound 50 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615131&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153106996 484204426 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310252 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(F)cc12)-c1ccccc1 |r| InChI=1S/C21H20FN3O3/c22-13-6-8-16-15(10-13)14(19(24-16)12-4-2-1-3-5-12)7-9-18(27)25-20-17(26)11-23-21(20)28/h1-6,8,10,17,20,24,26H,7,9,11H2,(H,23,28)(H,25,27) CIFMHGORNKEFCA-UHFFFAOYSA-N 615132 US20230271945, Compound 51 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615132&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147227272 484204427 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310253 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(F)cc12)-c1ccccc1 |r| InChI=1S/C21H20FN3O3/c22-13-6-8-16-15(10-13)14(19(24-16)12-4-2-1-3-5-12)7-9-18(27)25-20-17(26)11-23-21(20)28/h1-6,8,10,17,20,24,26H,7,9,11H2,(H,23,28)(H,25,27) CIFMHGORNKEFCA-UHFFFAOYSA-N 615132 US20230271945, Compound 51 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615132&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147227272 484204427 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310254 Fc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccccc1 |r| InChI=1S/C21H20FN3O2/c22-14-6-8-17-16(12-14)15(20(25-17)13-4-2-1-3-5-13)7-9-19(26)24-18-10-11-23-21(18)27/h1-6,8,12,18,25H,7,9-11H2,(H,23,27)(H,24,26) PJJFDCHQCGHHDO-UHFFFAOYSA-N 615133 US20230271945, Compound 52 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615133 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615133&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620091 484204428 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310255 Fc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccccc1 |r| InChI=1S/C21H20FN3O2/c22-14-6-8-17-16(12-14)15(20(25-17)13-4-2-1-3-5-13)7-9-19(26)24-18-10-11-23-21(18)27/h1-6,8,12,18,25H,7,9-11H2,(H,23,27)(H,24,26) PJJFDCHQCGHHDO-UHFFFAOYSA-N 615133 US20230271945, Compound 52 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615133 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615133&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620091 484204428 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310256 Fc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1cccc(c1)C#N |r| InChI=1S/C22H19FN4O2/c23-15-4-6-18-17(11-15)16(5-7-20(28)26-19-8-9-25-22(19)29)21(27-18)14-3-1-2-13(10-14)12-24/h1-4,6,10-11,19,27H,5,7-9H2,(H,25,29)(H,26,28) IVFVHHILIWRWCS-UHFFFAOYSA-N 615134 US20230271945, Compound 53 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615134&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147991892 484204429 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310257 Fc1ccc(cc1)-c1[nH]c2ccc(OCc3ccccc3)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C28H26FN3O3/c29-20-8-6-19(7-9-20)27-22(11-13-26(33)31-25-14-15-30-28(25)34)23-16-21(10-12-24(23)32-27)35-17-18-4-2-1-3-5-18/h1-10,12,16,25,32H,11,13-15,17H2,(H,30,34)(H,31,33) JICYERSNZJDUID-UHFFFAOYSA-N 615135 US20230271945, Compound 54 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615135&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148060455 484204430 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310258 Fc1ccc(cc1)-c1[nH]c2ccc(OCc3ccccc3)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C28H26FN3O3/c29-20-8-6-19(7-9-20)27-22(11-13-26(33)31-25-14-15-30-28(25)34)23-16-21(10-12-24(23)32-27)35-17-18-4-2-1-3-5-18/h1-10,12,16,25,32H,11,13-15,17H2,(H,30,34)(H,31,33) JICYERSNZJDUID-UHFFFAOYSA-N 615135 US20230271945, Compound 54 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615135&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148060455 484204430 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310259 Oc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(F)cc1 |r| InChI=1S/C21H20FN3O3/c22-13-3-1-12(2-4-13)20-15(16-11-14(26)5-7-17(16)25-20)6-8-19(27)24-18-9-10-23-21(18)28/h1-5,7,11,18,25-26H,6,8-10H2,(H,23,28)(H,24,27) ODZKYTIMHLKOEN-UHFFFAOYSA-N 615136 3-[5-benzyloxy-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S)-2-oxopyrrolidin-3-yl]propanamide (54) and 3-[2-(4-fluorophenyl)-5-hydroxy-1H-indol-3-yl]-N-[(3S)-2-oxopyrrolidin-3-yl]propanamide (55)::US20230271945, Compound 55 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615136&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620019 484204431 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310260 Oc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(F)cc1 |r| InChI=1S/C21H20FN3O3/c22-13-3-1-12(2-4-13)20-15(16-11-14(26)5-7-17(16)25-20)6-8-19(27)24-18-9-10-23-21(18)28/h1-5,7,11,18,25-26H,6,8-10H2,(H,23,28)(H,24,27) ODZKYTIMHLKOEN-UHFFFAOYSA-N 615136 3-[5-benzyloxy-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S)-2-oxopyrrolidin-3-yl]propanamide (54) and 3-[2-(4-fluorophenyl)-5-hydroxy-1H-indol-3-yl]-N-[(3S)-2-oxopyrrolidin-3-yl]propanamide (55)::US20230271945, Compound 55 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615136&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620019 484204431 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310261 COc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(F)cc1 |r| InChI=1S/C22H22FN3O3/c1-29-15-6-8-18-17(12-15)16(21(26-18)13-2-4-14(23)5-3-13)7-9-20(27)25-19-10-11-24-22(19)28/h2-6,8,12,19,26H,7,9-11H2,1H3,(H,24,28)(H,25,27) NOYHOJFREWMUIB-UHFFFAOYSA-N 615137 3-[2-(4-fluorophenyl)-5-methoxy-1H-indol-3-yl]-N-[(3S)-2-oxopyrrolidin-3-yl]propanamide (56)::US20230271945, Compound 56 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615137&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148667076 484204432 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310262 Fc1ccc(cc1)-c1[nH]c2c(F)c(F)ccc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H18F3N3O2/c22-12-3-1-11(2-4-12)19-13(14-5-7-15(23)18(24)20(14)27-19)6-8-17(28)26-16-9-10-25-21(16)29/h1-5,7,16,27H,6,8-10H2,(H,25,29)(H,26,28) CNDZKNMSENTEGP-UHFFFAOYSA-N 615138 US20230271945, Compound 57 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615138&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147253637 484204433 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310263 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)c(F)ccc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-12(13-5-7-14(23)17(24)19(13)27-18)6-8-16(29)26-20-15(28)9-25-21(20)30/h1-5,7,15,20,27-28H,6,8-9H2,(H,25,30)(H,26,29) TUTHIOMTXSKPRN-UHFFFAOYSA-N 615139 US20230271945, Compound 58 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615139&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 152848683 484204434 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310264 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)c(F)ccc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-12(13-5-7-14(23)17(24)19(13)27-18)6-8-16(29)26-20-15(28)9-25-21(20)30/h1-5,7,15,20,27-28H,6,8-9H2,(H,25,30)(H,26,29) TUTHIOMTXSKPRN-UHFFFAOYSA-N 615139 US20230271945, Compound 58 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615139&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 152848683 484204434 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310265 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)c(F)ccc12)-c1ccccc1 |r| InChI=1S/C21H19F2N3O3/c22-14-8-6-13-12(7-9-16(28)25-20-15(27)10-24-21(20)29)18(26-19(13)17(14)23)11-4-2-1-3-5-11/h1-6,8,15,20,26-27H,7,9-10H2,(H,24,29)(H,25,28) HQNWJESWGDGIEY-UHFFFAOYSA-N 615140 US20230271945, Compound 59 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615140&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961013 484204435 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310266 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)c(F)ccc12)-c1ccccc1 |r| InChI=1S/C21H19F2N3O3/c22-14-8-6-13-12(7-9-16(28)25-20-15(27)10-24-21(20)29)18(26-19(13)17(14)23)11-4-2-1-3-5-11/h1-6,8,15,20,26-27H,7,9-10H2,(H,24,29)(H,25,28) HQNWJESWGDGIEY-UHFFFAOYSA-N 615140 US20230271945, Compound 59 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615140&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961013 484204435 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310267 Fc1cccc2c(CCC(=O)N[C@H]3CCNC3=O)c([nH]c12)-c1ccccc1 |r| InChI=1S/C21H20FN3O2/c22-16-8-4-7-14-15(9-10-18(26)24-17-11-12-23-21(17)27)19(25-20(14)16)13-5-2-1-3-6-13/h1-8,17,25H,9-12H2,(H,23,27)(H,24,26) PFHXOZYAIKUHOI-UHFFFAOYSA-N 615141 US20230271945, Compound 60 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615141&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620155 484204436 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310268 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cccc12)-c1ccccc1 |r| InChI=1S/C21H20FN3O3/c22-15-8-4-7-13-14(18(25-19(13)15)12-5-2-1-3-6-12)9-10-17(27)24-20-16(26)11-23-21(20)28/h1-8,16,20,25-26H,9-11H2,(H,23,28)(H,24,27) CUZSXGJQLRGFIL-UHFFFAOYSA-N 50547878 CHEMBL4752052::US20230271945, Compound 61 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50547878 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50547878&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961231 461678218 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310269 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cccc12)-c1ccccc1 |r| InChI=1S/C21H20FN3O3/c22-15-8-4-7-13-14(18(25-19(13)15)12-5-2-1-3-6-12)9-10-17(27)24-20-16(26)11-23-21(20)28/h1-8,16,20,25-26H,9-11H2,(H,23,28)(H,24,27) CUZSXGJQLRGFIL-UHFFFAOYSA-N 50547878 CHEMBL4752052::US20230271945, Compound 61 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50547878 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50547878&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961231 461678218 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310270 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(C=C)cccc12)-c1ccccc1 |r| InChI=1S/C23H23N3O3/c1-2-14-9-6-10-16-17(21(26-20(14)16)15-7-4-3-5-8-15)11-12-19(28)25-22-18(27)13-24-23(22)29/h2-10,18,22,26-27H,1,11-13H2,(H,24,29)(H,25,28) UYXINXYFZBLGCE-UHFFFAOYSA-N 615143 N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]-3-(2-phenyl-7-vinyl-1H-indol-3-yl)propanamide (62)::US20230271945, Compound 62 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615143&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154941546 484204438 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310271 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cccc12)C1CC1)-c1ccccc1 |r| InChI=1S/C24H25N3O3/c28-19-13-25-24(30)23(19)26-20(29)12-11-18-17-8-4-7-16(14-9-10-14)22(17)27-21(18)15-5-2-1-3-6-15/h1-8,14,19,23,27-28H,9-13H2,(H,25,30)(H,26,29) CFRSIUAHRSDXLA-UHFFFAOYSA-N 615144 US20230271945, Compound 63 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615144 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615144&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620040 484204439 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310272 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cccc12)C1=CCOC1)-c1ccccc1 |r,t:24| InChI=1S/C25H25N3O4/c29-20-13-26-25(31)24(20)27-21(30)10-9-19-18-8-4-7-17(16-11-12-32-14-16)23(18)28-22(19)15-5-2-1-3-6-15/h1-8,11,20,24,28-29H,9-10,12-14H2,(H,26,31)(H,27,30) PUCGZEDCDJLYSG-UHFFFAOYSA-N 615145 US20230271945, Compound 64 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615145 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615145&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620113 484204440 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310273 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cccc12)C1CCOC1)-c1ccccc1 |r| InChI=1S/C25H27N3O4/c29-20-13-26-25(31)24(20)27-21(30)10-9-19-18-8-4-7-17(16-11-12-32-14-16)23(18)28-22(19)15-5-2-1-3-6-15/h1-8,16,20,24,28-29H,9-14H2,(H,26,31)(H,27,30) BOCGENGMXYYFEW-UHFFFAOYSA-N 615146 US20230271945, Compound 65 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615146 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615146&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147119620 484204441 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310274 CC(C)(O)c1cccc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccccc1 |r| InChI=1S/C24H27N3O4/c1-24(2,31)17-10-6-9-15-16(20(27-21(15)17)14-7-4-3-5-8-14)11-12-19(29)26-22-18(28)13-25-23(22)30/h3-10,18,22,27-28,31H,11-13H2,1-2H3,(H,25,30)(H,26,29) KLCAVNRTRKYHLS-UHFFFAOYSA-N 615147 US20230271945, Compound 66 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615147 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615147&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961636 484204442 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310275 CC(=C)c1cccc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccccc1 |r| InChI=1S/C24H25N3O3/c1-14(2)16-9-6-10-17-18(21(27-22(16)17)15-7-4-3-5-8-15)11-12-20(29)26-23-19(28)13-25-24(23)30/h3-10,19,23,27-28H,1,11-13H2,2H3,(H,25,30)(H,26,29) AUZVLAPCEHFHPL-UHFFFAOYSA-N 615148 US20230271945, Compound 67 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615148 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615148&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 155367063 484204443 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310276 CC(C)c1cccc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccccc1 |r| InChI=1S/C24H27N3O3/c1-14(2)16-9-6-10-17-18(21(27-22(16)17)15-7-4-3-5-8-15)11-12-20(29)26-23-19(28)13-25-24(23)30/h3-10,14,19,23,27-28H,11-13H2,1-2H3,(H,25,30)(H,26,29) AIDGSBCOLAYODF-UHFFFAOYSA-N 615149 US20230271945, Compound 68 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615149&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961665 484204444 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310277 Cc1cccc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccccc1 |r| InChI=1S/C22H23N3O3/c1-13-6-5-9-15-16(20(25-19(13)15)14-7-3-2-4-8-14)10-11-18(27)24-21-17(26)12-23-22(21)28/h2-9,17,21,25-26H,10-12H2,1H3,(H,23,28)(H,24,27) YEVJSYXSOPRKRO-UHFFFAOYSA-N 615150 US20230271945, Compound 69 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615150 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615150&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 149344692 484204445 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310278 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Br)cccc12)-c1ccccc1 |r| InChI=1S/C21H20BrN3O3/c22-15-8-4-7-13-14(18(25-19(13)15)12-5-2-1-3-6-12)9-10-17(27)24-20-16(26)11-23-21(20)28/h1-8,16,20,25-26H,9-11H2,(H,23,28)(H,24,27) OFUGSXYYDVNNEB-UHFFFAOYSA-N 615151 US20230271945, Compound 70 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615151&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961657 484204446 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310279 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Br)cccc12)-c1ccccc1 |r| InChI=1S/C21H20BrN3O3/c22-15-8-4-7-13-14(18(25-19(13)15)12-5-2-1-3-6-12)9-10-17(27)24-20-16(26)11-23-21(20)28/h1-8,16,20,25-26H,9-11H2,(H,23,28)(H,24,27) OFUGSXYYDVNNEB-UHFFFAOYSA-N 615151 US20230271945, Compound 70 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615151&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961657 484204446 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310280 Cc1cccc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| InChI=1S/C22H22FN3O3/c1-12-3-2-4-15-16(9-10-18(28)25-21-17(27)11-24-22(21)29)20(26-19(12)15)13-5-7-14(23)8-6-13/h2-8,17,21,26-27H,9-11H2,1H3,(H,24,29)(H,25,28) UZKJBFDYHRNRDN-UHFFFAOYSA-N 615152 US20230271945, Compound 71 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615152&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153007505 484204447 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310281 Fc1ccc(cc1)-c1[nH]c2c(Cl)cccc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H19ClFN3O2/c22-16-3-1-2-14-15(8-9-18(27)25-17-10-11-24-21(17)28)19(26-20(14)16)12-4-6-13(23)7-5-12/h1-7,17,26H,8-11H2,(H,24,28)(H,25,27) KKBLSBQXIZWNBG-UHFFFAOYSA-N 615153 US20230271945, Compound 72 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615153&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620007 484204448 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310282 Fc1ccc(cc1)-c1[nH]c2c(Cl)cccc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H19ClFN3O2/c22-16-3-1-2-14-15(8-9-18(27)25-17-10-11-24-21(17)28)19(26-20(14)16)12-4-6-13(23)7-5-12/h1-7,17,26H,8-11H2,(H,24,28)(H,25,27) KKBLSBQXIZWNBG-UHFFFAOYSA-N 615153 US20230271945, Compound 72 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615153&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620007 484204448 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310283 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Cl)cccc12)-c1ccc(F)cc1 |r| InChI=1S/C21H19ClFN3O3/c22-15-3-1-2-13-14(8-9-17(28)25-20-16(27)10-24-21(20)29)18(26-19(13)15)11-4-6-12(23)7-5-11/h1-7,16,20,26-27H,8-10H2,(H,24,29)(H,25,28) GPKZOZGWPYBGEP-UHFFFAOYSA-N 615154 US20230271945, Compound 73 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615154&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147682756 484204449 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310284 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Cl)cccc12)-c1ccc(F)cc1 |r| InChI=1S/C21H19ClFN3O3/c22-15-3-1-2-13-14(8-9-17(28)25-20-16(27)10-24-21(20)29)18(26-19(13)15)11-4-6-12(23)7-5-11/h1-7,16,20,26-27H,8-10H2,(H,24,29)(H,25,28) GPKZOZGWPYBGEP-UHFFFAOYSA-N 615154 US20230271945, Compound 73 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615154&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147682756 484204449 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310285 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Cl)cccc12)-c1ccccc1 |r| InChI=1S/C21H20ClN3O3/c22-15-8-4-7-13-14(18(25-19(13)15)12-5-2-1-3-6-12)9-10-17(27)24-20-16(26)11-23-21(20)28/h1-8,16,20,25-26H,9-11H2,(H,23,28)(H,24,27) RNDQARQPQPAMGV-UHFFFAOYSA-N 615155 US20230271945, Compound 74 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615155 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615155&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620063 484204450 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310286 Fc1ccc(cc1)-c1[nH]c2c(F)cccc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H19F2N3O2/c22-13-6-4-12(5-7-13)19-15(14-2-1-3-16(23)20(14)26-19)8-9-18(27)25-17-10-11-24-21(17)28/h1-7,17,26H,8-11H2,(H,24,28)(H,25,27) GBBSMTYNZFPQFR-UHFFFAOYSA-N 615156 US20230271945, Compound 75 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615156&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147606025 484204451 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310287 Fc1ccc(cc1)-c1[nH]c2c(F)cccc2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H19F2N3O2/c22-13-6-4-12(5-7-13)19-15(14-2-1-3-16(23)20(14)26-19)8-9-18(27)25-17-10-11-24-21(17)28/h1-7,17,26H,8-11H2,(H,24,28)(H,25,27) GBBSMTYNZFPQFR-UHFFFAOYSA-N 615156 US20230271945, Compound 75 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615156&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147606025 484204451 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310288 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cccc12)-c1ccc(F)cc1 |r| InChI=1S/C21H19F2N3O3/c22-12-6-4-11(5-7-12)18-14(13-2-1-3-15(23)19(13)26-18)8-9-17(28)25-20-16(27)10-24-21(20)29/h1-7,16,20,26-27H,8-10H2,(H,24,29)(H,25,28) HNNHROBQXNMZEM-UHFFFAOYSA-N 615157 US20230271945, Compound 76 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615157&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147811848 484204452 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310289 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cccc12)-c1ccc(F)cc1 |r| InChI=1S/C21H19F2N3O3/c22-12-6-4-11(5-7-12)18-14(13-2-1-3-15(23)19(13)26-18)8-9-17(28)25-20-16(27)10-24-21(20)29/h1-7,16,20,26-27H,8-10H2,(H,24,29)(H,25,28) HNNHROBQXNMZEM-UHFFFAOYSA-N 615157 US20230271945, Compound 76 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615157&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147811848 484204452 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310290 COc1cccc2c(CCC(=O)N[C@H]3CCNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| InChI=1S/C22H22FN3O3/c1-29-18-4-2-3-15-16(9-10-19(27)25-17-11-12-24-22(17)28)20(26-21(15)18)13-5-7-14(23)8-6-13/h2-8,17,26H,9-12H2,1H3,(H,24,28)(H,25,27) VOCGJJHMQASZHO-UHFFFAOYSA-N 615158 US20230271945, Compound 77 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615158 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615158&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620054 484204453 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310291 Fc1ccc(cc1)-c1[nH]c2c(F)ccc(F)c2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H18F3N3O2/c22-12-3-1-11(2-4-12)19-13(18-14(23)6-7-15(24)20(18)27-19)5-8-17(28)26-16-9-10-25-21(16)29/h1-4,6-7,16,27H,5,8-10H2,(H,25,29)(H,26,28) BDCYCWHNSBCRQR-UHFFFAOYSA-N 615159 US20230271945, Compound 78 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615159&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619954 484204454 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310292 Fc1ccc(cc1)-c1[nH]c2c(F)ccc(F)c2c1CCC(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H18F3N3O2/c22-12-3-1-11(2-4-12)19-13(18-14(23)6-7-15(24)20(18)27-19)5-8-17(28)26-16-9-10-25-21(16)29/h1-4,6-7,16,27H,5,8-10H2,(H,25,29)(H,26,28) BDCYCWHNSBCRQR-UHFFFAOYSA-N 615159 US20230271945, Compound 78 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615159&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619954 484204454 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310293 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)c(F)c(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H17F4N3O3/c22-10-3-1-9(2-4-10)18-11(12-7-13(23)16(24)17(25)19(12)28-18)5-6-15(30)27-20-14(29)8-26-21(20)31/h1-4,7,14,20,28-29H,5-6,8H2,(H,26,31)(H,27,30) RKKFMUJQZIIHBZ-UHFFFAOYSA-N 615160 US20230271945, Compound 79 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615160&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961639 484204455 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310294 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)c(F)c(F)cc12)-c1ccccc1 |r| InChI=1S/C21H18F3N3O3/c22-13-8-12-11(6-7-15(29)26-20-14(28)9-25-21(20)30)18(10-4-2-1-3-5-10)27-19(12)17(24)16(13)23/h1-5,8,14,20,27-28H,6-7,9H2,(H,25,30)(H,26,29) CIETZPUPOIFVKR-UHFFFAOYSA-N 615161 US20230271945, Compound 80 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615161&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620049 484204456 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310295 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)c(F)c(F)cc12)-c1ccccc1 |r| InChI=1S/C21H18F3N3O3/c22-13-8-12-11(6-7-15(29)26-20-14(28)9-25-21(20)30)18(10-4-2-1-3-5-10)27-19(12)17(24)16(13)23/h1-5,8,14,20,27-28H,6-7,9H2,(H,25,30)(H,26,29) CIETZPUPOIFVKR-UHFFFAOYSA-N 615161 US20230271945, Compound 80 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615161&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620049 484204456 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310296 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2cc(F)c(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)19-12(13-7-14(23)15(24)8-16(13)26-19)5-6-18(29)27-20-17(28)9-25-21(20)30/h1-4,7-8,17,20,26,28H,5-6,9H2,(H,25,30)(H,27,29) CBVCLVDILBVRMY-UHFFFAOYSA-N 615162 US20230271945, Compound 81 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615162&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961641 484204457 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310297 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2cc(F)c(F)cc12)-c1ccccc1 |r| InChI=1S/C21H19F2N3O3/c22-14-8-13-12(6-7-18(28)26-20-17(27)10-24-21(20)29)19(11-4-2-1-3-5-11)25-16(13)9-15(14)23/h1-5,8-9,17,20,25,27H,6-7,10H2,(H,24,29)(H,26,28) OLCNCVPOHSMJCH-UHFFFAOYSA-N 50547879 CHEMBL4780017::US20230271945, Compound 82 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50547879 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50547879&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961808 461678219 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310298 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2cc(F)c(F)cc12)-c1ccccc1 |r| InChI=1S/C21H19F2N3O3/c22-14-8-13-12(6-7-18(28)26-20-17(27)10-24-21(20)29)19(11-4-2-1-3-5-11)25-16(13)9-15(14)23/h1-5,8-9,17,20,25,27H,6-7,10H2,(H,24,29)(H,26,28) OLCNCVPOHSMJCH-UHFFFAOYSA-N 50547879 CHEMBL4780017::US20230271945, Compound 82 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50547879 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50547879&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961808 461678219 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310299 Cc1c(F)ccc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| InChI=1S/C22H21F2N3O3/c1-11-16(24)8-6-14-15(7-9-18(29)26-21-17(28)10-25-22(21)30)20(27-19(11)14)12-2-4-13(23)5-3-12/h2-6,8,17,21,27-28H,7,9-10H2,1H3,(H,25,30)(H,26,29) PRQXHGNPLPWTRA-UHFFFAOYSA-N 615164 US20230271945, Compound 83 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615164&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961687 484204459 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310300 Cc1c(F)ccc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccccc1 |r| InChI=1S/C22H22FN3O3/c1-12-16(23)9-7-14-15(20(26-19(12)14)13-5-3-2-4-6-13)8-10-18(28)25-21-17(27)11-24-22(21)29/h2-7,9,17,21,26-27H,8,10-11H2,1H3,(H,24,29)(H,25,28) BZUIUDQGEWHYNC-UHFFFAOYSA-N 615165 US20230271945, Compound 84 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615165&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961232 484204460 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310301 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2cc(F)cc(F)c12)-c1ccccc1 |r| InChI=1S/C21H19F2N3O3/c22-12-8-14(23)18-13(6-7-17(28)26-20-16(27)10-24-21(20)29)19(25-15(18)9-12)11-4-2-1-3-5-11/h1-5,8-9,16,20,25,27H,6-7,10H2,(H,24,29)(H,26,28) DAJOBEPPPQVRQO-UHFFFAOYSA-N 615166 US20230271945, Compound 85 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615166&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961019 484204461 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310302 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2cc(F)cc(F)c12)-c1ccccc1 |r| InChI=1S/C21H19F2N3O3/c22-12-8-14(23)18-13(6-7-17(28)26-20-16(27)10-24-21(20)29)19(25-15(18)9-12)11-4-2-1-3-5-11/h1-5,8-9,16,20,25,27H,6-7,10H2,(H,24,29)(H,26,28) DAJOBEPPPQVRQO-UHFFFAOYSA-N 615166 US20230271945, Compound 85 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615166&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961019 484204461 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310303 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccccc1 |r| InChI=1S/C21H21N3O3/c25-17-12-22-21(27)20(17)24-18(26)11-10-15-14-8-4-5-9-16(14)23-19(15)13-6-2-1-3-7-13/h1-9,17,20,23,25H,10-12H2,(H,22,27)(H,24,26) ZRPZFZCPHXQZNT-UHFFFAOYSA-N 615167 US20230271945, Compound 86 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615167&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 149557842 484204462 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310304 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccccc1 |r| InChI=1S/C21H21N3O3/c25-17-12-22-21(27)20(17)24-18(26)11-10-15-14-8-4-5-9-16(14)23-19(15)13-6-2-1-3-7-13/h1-9,17,20,23,25H,10-12H2,(H,22,27)(H,24,26) ZRPZFZCPHXQZNT-UHFFFAOYSA-N 615167 US20230271945, Compound 86 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615167&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 149557842 484204462 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310305 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(F)cc1 |r| InChI=1S/C21H20FN3O3/c22-13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)24-19)9-10-18(27)25-20-17(26)11-23-21(20)28/h1-8,17,20,24,26H,9-11H2,(H,23,28)(H,25,27) CNYZYDUBGMRAFP-UHFFFAOYSA-N 615168 US20230271945, Compound 87 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615168 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615168&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147257822 484204463 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310306 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(F)cc1 |r| InChI=1S/C21H20FN3O3/c22-13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)24-19)9-10-18(27)25-20-17(26)11-23-21(20)28/h1-8,17,20,24,26H,9-11H2,(H,23,28)(H,25,27) CNYZYDUBGMRAFP-UHFFFAOYSA-N 615168 US20230271945, Compound 87 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615168 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615168&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147257822 484204463 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310307 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-13(14-7-12(23)8-15(24)19(14)27-18)5-6-17(29)26-20-16(28)9-25-21(20)30/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) CTXLPYZCBOVVQK-UHFFFAOYSA-N 615085 US20230271945, Compound 2::3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (2)::US20230271945, Compound 88::US20230271945, Compound 89 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615085&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147289591 484204381 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310308 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-13(14-7-12(23)8-15(24)19(14)27-18)5-6-17(29)26-20-16(28)9-25-21(20)30/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) CTXLPYZCBOVVQK-UHFFFAOYSA-N 615085 US20230271945, Compound 2::3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (2)::US20230271945, Compound 88::US20230271945, Compound 89 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615085&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147289591 484204381 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310309 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-13(14-7-12(23)8-15(24)19(14)27-18)5-6-17(29)26-20-16(28)9-25-21(20)30/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) CTXLPYZCBOVVQK-UHFFFAOYSA-N 615085 US20230271945, Compound 2::3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (2)::US20230271945, Compound 88::US20230271945, Compound 89 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615085&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147289591 484204381 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310310 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-13(14-7-12(23)8-15(24)19(14)27-18)5-6-17(29)26-20-16(28)9-25-21(20)30/h1-4,7-8,16,20,27-28H,5-6,9H2,(H,25,30)(H,26,29) CTXLPYZCBOVVQK-UHFFFAOYSA-N 615085 US20230271945, Compound 2::3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (2)::US20230271945, Compound 88::US20230271945, Compound 89 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615085&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147289591 484204381 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310311 C[C@@H](Cc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1)C(=O)N[C@H]1CCNC1=O |r| InChI=1S/C22H20F3N3O2/c1-11(21(29)27-18-6-7-26-22(18)30)8-15-16-9-14(24)10-17(25)20(16)28-19(15)12-2-4-13(23)5-3-12/h2-5,9-11,18,28H,6-8H2,1H3,(H,26,30)(H,27,29) SZTXPOUIZOFPRI-UHFFFAOYSA-N 615171 (2S)-3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-2-methyl-N-[(3S)-2-oxopyrrolidin-3-yl]propanamide (90)::US20230271945, Compound 90 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615171&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619939 484204464 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310312 C[C@@H](Cc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1)C(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C22H20F3N3O3/c1-10(21(30)28-20-17(29)9-26-22(20)31)6-14-15-7-13(24)8-16(25)19(15)27-18(14)11-2-4-12(23)5-3-11/h2-5,7-8,10,17,20,27,29H,6,9H2,1H3,(H,26,31)(H,28,30) VYINBTJUTHARFV-UHFFFAOYSA-N 615172 (2S)-3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]-2-methyl-propanamide (91)::US20230271945, Compound 91 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615172&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 152216407 484204465 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310313 O[C@H](Cc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1)C(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C21H18F3N3O4/c22-10-3-1-9(2-4-10)17-13(12-5-11(23)6-14(24)18(12)26-17)7-15(28)20(30)27-19-16(29)8-25-21(19)31/h1-6,15-16,19,26,28-29H,7-8H2,(H,25,31)(H,27,30) JSFRBEYIFVWHRW-UHFFFAOYSA-N 615173 (2R)-3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-2-hydroxy-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (92)::US20230271945, Compound 92 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615173&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148115943 484204466 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310314 O[C@H](Cc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1)C(=O)N[C@H]1CCNC1=O |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-10(2-4-11)18-14(13-7-12(23)8-15(24)19(13)27-18)9-17(28)21(30)26-16-5-6-25-20(16)29/h1-4,7-8,16-17,27-28H,5-6,9H2,(H,25,29)(H,26,30) NNXRSUUGSKIHDK-UHFFFAOYSA-N 615174 (2R)-3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-2-hydroxy-N-[(3S)-2-oxopyrrolidin-3-yl]propanamide (93)::US20230271945, Compound 93 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615174 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615174&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148661745 484204467 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310315 O[C@@H](Cc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1)C(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C21H18F3N3O4/c22-10-3-1-9(2-4-10)17-13(12-5-11(23)6-14(24)18(12)26-17)7-15(28)20(30)27-19-16(29)8-25-21(19)31/h1-6,15-16,19,26,28-29H,7-8H2,(H,25,31)(H,27,30) JSFRBEYIFVWHRW-UHFFFAOYSA-N 615175 (2S)-3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-2-hydroxy-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (94)::US20230271945, Compound 94 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615175&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148115942 484204468 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310316 O[C@@H]1CNC(=O)[C@H]1NC(=O)C(F)(F)Cc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H16F5N3O3/c22-10-3-1-9(2-4-10)16-13(12-5-11(23)6-14(24)17(12)28-16)7-21(25,26)20(32)29-18-15(30)8-27-19(18)31/h1-6,15,18,28,30H,7-8H2,(H,27,31)(H,29,32) BNUIRHNFJMWRLI-UHFFFAOYSA-N 615176 3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-2,2-difluoro-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (95)::US20230271945, Compound 95 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615176&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620085 484204469 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310317 O[C@@H]1CNC(=O)[C@H]1NC(=O)C(F)(F)Cc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C21H16F5N3O3/c22-10-3-1-9(2-4-10)16-13(12-5-11(23)6-14(24)17(12)28-16)7-21(25,26)20(32)29-18-15(30)8-27-19(18)31/h1-6,15,18,28,30H,7-8H2,(H,27,31)(H,29,32) BNUIRHNFJMWRLI-UHFFFAOYSA-N 615176 3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-2,2-difluoro-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (95)::US20230271945, Compound 95 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615176&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620085 484204469 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310318 CC(CC(=O)N[C@H]1CCNC1=O)c1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r,w:1.0| InChI=1S/C22H20F3N3O2/c1-11(8-18(29)27-17-6-7-26-22(17)30)19-15-9-14(24)10-16(25)21(15)28-20(19)12-2-4-13(23)5-3-12/h2-5,9-11,17,28H,6-8H2,1H3,(H,26,30)(H,27,29) NFTLLEITAGWWNE-UHFFFAOYSA-N 615177 3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]butanoic acid (96)::US20230271945, Compound 96 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615177&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 151188237 484204470 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310319 CC(CC(=O)N[C@H]1[C@H](O)CNC1=O)c1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r,w:1.0| InChI=1S/C22H20F3N3O3/c1-10(6-17(30)27-21-16(29)9-26-22(21)31)18-14-7-13(24)8-15(25)20(14)28-19(18)11-2-4-12(23)5-3-11/h2-5,7-8,10,16,21,28-29H,6,9H2,1H3,(H,26,31)(H,27,30) BUKWJIDXEIHXMO-UHFFFAOYSA-N 615178 3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]butanamide (97)::US20230271945, Compound 97 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615178&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 149837439 484204471 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310320 Cc1c(F)c(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| InChI=1S/C22H20F3N3O3/c1-10-18(25)15(24)8-14-13(6-7-17(30)27-21-16(29)9-26-22(21)31)20(28-19(10)14)11-2-4-12(23)5-3-11/h2-5,8,16,21,28-29H,6-7,9H2,1H3,(H,26,31)(H,27,30) GTRQAWUYYYUBJU-UHFFFAOYSA-N 615179 3-[5,6-difluoro-2-(4-fluorophenyl)-7-methyl-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (98)::US20230271945, Compound 98 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615179&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619950 484204472 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310321 Cc1c(F)c(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| InChI=1S/C22H20F3N3O3/c1-10-18(25)15(24)8-14-13(6-7-17(30)27-21-16(29)9-26-22(21)31)20(28-19(10)14)11-2-4-12(23)5-3-11/h2-5,8,16,21,28-29H,6-7,9H2,1H3,(H,26,31)(H,27,30) GTRQAWUYYYUBJU-UHFFFAOYSA-N 615179 3-[5,6-difluoro-2-(4-fluorophenyl)-7-methyl-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (98)::US20230271945, Compound 98 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615179&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619950 484204472 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310322 Cc1c(F)c(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccccc1 |r| InChI=1S/C22H21F2N3O3/c1-11-18(24)15(23)9-14-13(20(27-19(11)14)12-5-3-2-4-6-12)7-8-17(29)26-21-16(28)10-25-22(21)30/h2-6,9,16,21,27-28H,7-8,10H2,1H3,(H,25,30)(H,26,29) JZJZTEUFRPMFHH-UHFFFAOYSA-N 615180 3-(5,6-difluoro-7-methyl-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (99)::US20230271945, Compound 99 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615180&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619970 484204473 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310323 Cc1c(F)c(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccccc1 |r| InChI=1S/C22H21F2N3O3/c1-11-18(24)15(23)9-14-13(20(27-19(11)14)12-5-3-2-4-6-12)7-8-17(29)26-21-16(28)10-25-22(21)30/h2-6,9,16,21,27-28H,7-8,10H2,1H3,(H,25,30)(H,26,29) JZJZTEUFRPMFHH-UHFFFAOYSA-N 615180 3-(5,6-difluoro-7-methyl-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (99)::US20230271945, Compound 99 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615180&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619970 484204473 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310324 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cc(F)cc12)C(F)F)-c1ccc(F)cc1 |r| InChI=1S/C22H19F4N3O3/c23-11-3-1-10(2-4-11)18-13(5-6-17(31)28-20-16(30)9-27-22(20)32)14-7-12(24)8-15(21(25)26)19(14)29-18/h1-4,7-8,16,20-21,29-30H,5-6,9H2,(H,27,32)(H,28,31) LLXDFYFGVUMKEM-UHFFFAOYSA-N 615181 3-[7-(difluoromethyl)-5-fluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (100)::US20230271945, Compound 100 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615181 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615181&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148368802 484204474 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310325 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(cc12)C(F)(F)F)-c1ccc(F)cc1 |r| InChI=1S/C22H18F5N3O3/c23-12-3-1-10(2-4-12)18-13(5-6-17(32)29-20-16(31)9-28-21(20)33)14-7-11(22(25,26)27)8-15(24)19(14)30-18/h1-4,7-8,16,20,30-31H,5-6,9H2,(H,28,33)(H,29,32) ANBNTRMWCWBMRD-UHFFFAOYSA-N 615182 3-[7-fluoro-2-(4-fluorophenyl)-5-(trifluoromethyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (101)::US20230271945, Compound 101 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615182&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 146974450 484204475 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310326 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(cc12)C(F)(F)F)-c1ccc(F)cc1 |r| InChI=1S/C22H18F5N3O3/c23-12-3-1-10(2-4-12)18-13(5-6-17(32)29-20-16(31)9-28-21(20)33)14-7-11(22(25,26)27)8-15(24)19(14)30-18/h1-4,7-8,16,20,30-31H,5-6,9H2,(H,28,33)(H,29,32) ANBNTRMWCWBMRD-UHFFFAOYSA-N 615182 3-[7-fluoro-2-(4-fluorophenyl)-5-(trifluoromethyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (101)::US20230271945, Compound 101 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615182&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 146974450 484204475 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310327 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(OC(F)F)cc1 |r| InChI=1S/C22H19F4N3O4/c23-11-7-14-13(5-6-17(31)28-20-16(30)9-27-21(20)32)18(29-19(14)15(24)8-11)10-1-3-12(4-2-10)33-22(25)26/h1-4,7-8,16,20,22,29-30H,5-6,9H2,(H,27,32)(H,28,31) PXXLOSKKHPBAPW-UHFFFAOYSA-N 615183 US20230271945, Compound 102 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615183&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148992164 484204476 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310328 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(OC(F)F)cc1 |r| InChI=1S/C22H19F4N3O4/c23-11-7-14-13(5-6-17(31)28-20-16(30)9-27-21(20)32)18(29-19(14)15(24)8-11)10-1-3-12(4-2-10)33-22(25)26/h1-4,7-8,16,20,22,29-30H,5-6,9H2,(H,27,32)(H,28,31) PXXLOSKKHPBAPW-UHFFFAOYSA-N 615183 US20230271945, Compound 102 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615183&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148992164 484204476 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310329 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1cccc(F)c1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-2-10(6-11)18-13(14-7-12(23)8-15(24)19(14)27-18)4-5-17(29)26-20-16(28)9-25-21(20)30/h1-3,6-8,16,20,27-28H,4-5,9H2,(H,25,30)(H,26,29) YCTXWSCWGVDURT-UHFFFAOYSA-N 615184 US20230271945, Compound 103 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615184&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 149333491 484204477 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310330 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1cccc(F)c1 |r| InChI=1S/C21H18F3N3O3/c22-11-3-1-2-10(6-11)18-13(14-7-12(23)8-15(24)19(14)27-18)4-5-17(29)26-20-16(28)9-25-21(20)30/h1-3,6-8,16,20,27-28H,4-5,9H2,(H,25,30)(H,26,29) YCTXWSCWGVDURT-UHFFFAOYSA-N 615184 US20230271945, Compound 103 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615184&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 149333491 484204477 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310331 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1cc(F)cc(F)c1 |r| InChI=1S/C21H17F4N3O3/c22-10-3-9(4-11(23)5-10)18-13(14-6-12(24)7-15(25)19(14)28-18)1-2-17(30)27-20-16(29)8-26-21(20)31/h3-7,16,20,28-29H,1-2,8H2,(H,26,31)(H,27,30) KKMCHJOGAGOLDC-UHFFFAOYSA-N 615185 US20230271945, Compound 104 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615185&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620065 484204478 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310332 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1cc(F)cc(F)c1 |r| InChI=1S/C21H17F4N3O3/c22-10-3-9(4-11(23)5-10)18-13(14-6-12(24)7-15(25)19(14)28-18)1-2-17(30)27-20-16(29)8-26-21(20)31/h3-7,16,20,28-29H,1-2,8H2,(H,26,31)(H,27,30) KKMCHJOGAGOLDC-UHFFFAOYSA-N 615185 US20230271945, Compound 104 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615185&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620065 484204478 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310333 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)c(F)c1 |r| InChI=1S/C21H17F4N3O3/c22-10-6-12-11(2-4-17(30)27-20-16(29)8-26-21(20)31)18(28-19(12)15(25)7-10)9-1-3-13(23)14(24)5-9/h1,3,5-7,16,20,28-29H,2,4,8H2,(H,26,31)(H,27,30) BXBGQWDJOYEUDD-UHFFFAOYSA-N 615186 US20230271945, Compound 105 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615186&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619978 484204479 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310334 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)c(F)c1 |r| InChI=1S/C21H17F4N3O3/c22-10-6-12-11(2-4-17(30)27-20-16(29)8-26-21(20)31)18(28-19(12)15(25)7-10)9-1-3-13(23)14(24)5-9/h1,3,5-7,16,20,28-29H,2,4,8H2,(H,26,31)(H,27,30) BXBGQWDJOYEUDD-UHFFFAOYSA-N 615186 US20230271945, Compound 105 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615186&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619978 484204479 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310335 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(OC(F)F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C22H19F4N3O4/c23-11-3-1-10(2-4-11)18-13(5-6-17(31)28-20-16(30)9-27-21(20)32)14-7-12(33-22(25)26)8-15(24)19(14)29-18/h1-4,7-8,16,20,22,29-30H,5-6,9H2,(H,27,32)(H,28,31) ZMQHBVVHXWMNKA-UHFFFAOYSA-N 615187 US20230271945, Compound 106 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615187&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961659 484204480 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310336 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(OC(F)F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C22H19F4N3O4/c23-11-3-1-10(2-4-11)18-13(5-6-17(31)28-20-15(30)9-27-21(20)32)14-7-12(24)8-16(19(14)29-18)33-22(25)26/h1-4,7-8,15,20,22,29-30H,5-6,9H2,(H,27,32)(H,28,31) NGZYMASRJYIVAD-UHFFFAOYSA-N 615188 US20230271945, Compound 107 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615188&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148624966 484204481 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310337 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(OC(F)F)cc(F)cc12)-c1ccc(F)cc1 |r| InChI=1S/C22H19F4N3O4/c23-11-3-1-10(2-4-11)18-13(5-6-17(31)28-20-15(30)9-27-21(20)32)14-7-12(24)8-16(19(14)29-18)33-22(25)26/h1-4,7-8,15,20,22,29-30H,5-6,9H2,(H,27,32)(H,28,31) NGZYMASRJYIVAD-UHFFFAOYSA-N 615188 US20230271945, Compound 107 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615188&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148624966 484204481 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310338 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(cc12)C(F)(F)F)-c1ccc(F)cc1 |r| InChI=1S/C22H19F4N3O3/c23-13-4-1-11(2-5-13)19-14(6-8-18(31)29-20-17(30)10-27-21(20)32)15-9-12(22(24,25)26)3-7-16(15)28-19/h1-5,7,9,17,20,28,30H,6,8,10H2,(H,27,32)(H,29,31) AZZPHHIPMVTBJD-UHFFFAOYSA-N 615189 3-[2-(4-fluorophenyl)-5-(trifluoromethyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (108)::US20230271945, Compound 108 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615189&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 149735073 484204482 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310339 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(cc12)C(F)(F)F)-c1ccc(F)cc1 |r| InChI=1S/C22H19F4N3O3/c23-13-4-1-11(2-5-13)19-14(6-8-18(31)29-20-17(30)10-27-21(20)32)15-9-12(22(24,25)26)3-7-16(15)28-19/h1-5,7,9,17,20,28,30H,6,8,10H2,(H,27,32)(H,29,31) AZZPHHIPMVTBJD-UHFFFAOYSA-N 615189 3-[2-(4-fluorophenyl)-5-(trifluoromethyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (108)::US20230271945, Compound 108 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615189&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 149735073 484204482 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310340 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2cc(F)ccc12)-c1ccccc1 |r| InChI=1S/C21H20FN3O3/c22-13-6-7-14-15(8-9-18(27)25-20-17(26)11-23-21(20)28)19(24-16(14)10-13)12-4-2-1-3-5-12/h1-7,10,17,20,24,26H,8-9,11H2,(H,23,28)(H,25,27) XUDAJNJUXJJPHI-UHFFFAOYSA-N 615190 3-(6-fluoro-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (109)::US20230271945, Compound 109 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615190&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619974 484204483 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310341 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2cc(F)ccc12)-c1ccccc1 |r| InChI=1S/C21H20FN3O3/c22-13-6-7-14-15(8-9-18(27)25-20-17(26)11-23-21(20)28)19(24-16(14)10-13)12-4-2-1-3-5-12/h1-7,10,17,20,24,26H,8-9,11H2,(H,23,28)(H,25,27) XUDAJNJUXJJPHI-UHFFFAOYSA-N 615190 3-(6-fluoro-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (109)::US20230271945, Compound 109 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615190&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619974 484204483 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310342 O[C@H]1CNC(=O)[C@@H]1NC(=O)CCc1c([nH]c2cc(O)ccc12)-c1ccc(F)cc1 |r| InChI=1S/C21H20FN3O4/c22-12-3-1-11(2-4-12)19-15(14-6-5-13(26)9-16(14)24-19)7-8-18(28)25-20-17(27)10-23-21(20)29/h1-6,9,17,20,24,26-27H,7-8,10H2,(H,23,29)(H,25,28) APYSSCWRYPKBTP-UHFFFAOYSA-N 615191 3-[2-(4-fluorophenyl)-6-hydroxy-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (110)::US20230271945, Compound 110 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615191&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961023 484204484 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310343 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cccc12)C(F)(F)F)-c1ccc(F)cc1 |r| InChI=1S/C22H19F4N3O3/c23-12-6-4-11(5-7-12)18-14(8-9-17(31)28-20-16(30)10-27-21(20)32)13-2-1-3-15(19(13)29-18)22(24,25)26/h1-7,16,20,29-30H,8-10H2,(H,27,32)(H,28,31) OSORDUZRPHZQJF-UHFFFAOYSA-N 615192 3-[2-(4-fluorophenyl)-7-(trifluoromethyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (111)::US20230271945, Compound 111 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615192&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619935 484204485 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310344 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cccc12)C(F)(F)F)-c1ccccc1 |r| InChI=1S/C22H20F3N3O3/c23-22(24,25)15-8-4-7-13-14(18(28-19(13)15)12-5-2-1-3-6-12)9-10-17(30)27-20-16(29)11-26-21(20)31/h1-8,16,20,28-29H,9-11H2,(H,26,31)(H,27,30) LKARTLDYTQXNDZ-UHFFFAOYSA-N 615193 N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]-3-[2-phenyl-7-(trifluoromethyl)-1H-indol-3-yl]propanamide (112)::US20230271945, Compound 112 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615193&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148359323 484204486 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310345 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cccc12)C(F)(F)F)-c1ccccc1 |r| InChI=1S/C22H20F3N3O3/c23-22(24,25)15-8-4-7-13-14(18(28-19(13)15)12-5-2-1-3-6-12)9-10-17(30)27-20-16(29)11-26-21(20)31/h1-8,16,20,28-29H,9-11H2,(H,26,31)(H,27,30) LKARTLDYTQXNDZ-UHFFFAOYSA-N 615193 N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]-3-[2-phenyl-7-(trifluoromethyl)-1H-indol-3-yl]propanamide (112)::US20230271945, Compound 112 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615193&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 148359323 484204486 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310346 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Cl)cccc12)-c1ccc(Cl)cc1 |r| InChI=1S/C21H19Cl2N3O3/c22-12-6-4-11(5-7-12)18-14(13-2-1-3-15(23)19(13)26-18)8-9-17(28)25-20-16(27)10-24-21(20)29/h1-7,16,20,26-27H,8-10H2,(H,24,29)(H,25,28) SZNOIUIQMZMLOH-UHFFFAOYSA-N 615194 3-[7-chloro-2-(4-chlorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (113)::US20230271945, Compound 113 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615194&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620126 484204487 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310347 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2cccc(F)c12)-c1ccccc1 |r| InChI=1S/C21H20FN3O3/c22-14-7-4-8-15-18(14)13(19(24-15)12-5-2-1-3-6-12)9-10-17(27)25-20-16(26)11-23-21(20)28/h1-8,16,20,24,26H,9-11H2,(H,23,28)(H,25,27) ALXURLGJJHPQLW-UHFFFAOYSA-N 615195 3-(4-fluoro-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (114)::US20230271945, Compound 114 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615195&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 146968258 484204488 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310348 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2cccc(F)c12)-c1ccccc1 |r| InChI=1S/C21H20FN3O3/c22-14-7-4-8-15-18(14)13(19(24-15)12-5-2-1-3-6-12)9-10-17(27)25-20-16(26)11-23-21(20)28/h1-8,16,20,24,26H,9-11H2,(H,23,28)(H,25,27) ALXURLGJJHPQLW-UHFFFAOYSA-N 615195 3-(4-fluoro-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (114)::US20230271945, Compound 114 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615195&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 146968258 484204488 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310349 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(cc1)C#N |r| InChI=1S/C22H20N4O3/c23-11-13-5-7-14(8-6-13)20-16(15-3-1-2-4-17(15)25-20)9-10-19(28)26-21-18(27)12-24-22(21)29/h1-8,18,21,25,27H,9-10,12H2,(H,24,29)(H,26,28) LPVIQAJHCAJYSI-UHFFFAOYSA-N 615196 3-[2-(4-cyanophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (116)::US20230271945, Compound 116 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615196&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 150979724 484204489 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310350 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(cc1)C#N |r| InChI=1S/C22H20N4O3/c23-11-13-5-7-14(8-6-13)20-16(15-3-1-2-4-17(15)25-20)9-10-19(28)26-21-18(27)12-24-22(21)29/h1-8,18,21,25,27H,9-10,12H2,(H,24,29)(H,26,28) LPVIQAJHCAJYSI-UHFFFAOYSA-N 615196 3-[2-(4-cyanophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (116)::US20230271945, Compound 116 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615196&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 150979724 484204489 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310351 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(OC(F)F)cc1 |r| InChI=1S/C22H21F2N3O4/c23-22(24)31-13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)26-19)9-10-18(29)27-20-17(28)11-25-21(20)30/h1-8,17,20,22,26,28H,9-11H2,(H,25,30)(H,27,29) FSZSQPWGCOWFRR-UHFFFAOYSA-N 615197 US20230271945, Compound 117 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615197&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147562981 484204490 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310352 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(OC(F)(F)F)cc1 |r| InChI=1S/C22H20F3N3O4/c23-22(24,25)32-13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)27-19)9-10-18(30)28-20-17(29)11-26-21(20)31/h1-8,17,20,27,29H,9-11H2,(H,26,31)(H,28,30) YLTJKCYYVVFWOH-UHFFFAOYSA-N 615198 US20230271945, Compound 118 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615198&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961045 484204491 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310353 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(OC(F)(F)F)cc1 |r| InChI=1S/C22H20F3N3O4/c23-22(24,25)32-13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)27-19)9-10-18(30)28-20-17(29)11-26-21(20)31/h1-8,17,20,27,29H,9-11H2,(H,26,31)(H,28,30) YLTJKCYYVVFWOH-UHFFFAOYSA-N 615198 US20230271945, Compound 118 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615198&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961045 484204491 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310354 Cc1cc(F)ccc1-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C22H22FN3O3/c1-12-10-13(23)6-7-14(12)20-16(15-4-2-3-5-17(15)25-20)8-9-19(28)26-21-18(27)11-24-22(21)29/h2-7,10,18,21,25,27H,8-9,11H2,1H3,(H,24,29)(H,26,28) BBHLJHHSIVQCFK-UHFFFAOYSA-N 615199 US20230271945, Compound 119 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615199&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147051002 484204492 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310355 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(Cl)c(F)c1 |r| InChI=1S/C21H19ClFN3O3/c22-14-7-5-11(9-15(14)23)19-13(12-3-1-2-4-16(12)25-19)6-8-18(28)26-20-17(27)10-24-21(20)29/h1-5,7,9,17,20,25,27H,6,8,10H2,(H,24,29)(H,26,28) WJIAVCXVDFYCSF-UHFFFAOYSA-N 615200 US20230271945, Compound 120 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615200&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620009 484204493 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310356 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(Cl)c(F)c1 |r| InChI=1S/C21H19ClFN3O3/c22-14-7-5-11(9-15(14)23)19-13(12-3-1-2-4-16(12)25-19)6-8-18(28)26-20-17(27)10-24-21(20)29/h1-5,7,9,17,20,25,27H,6,8,10H2,(H,24,29)(H,26,28) WJIAVCXVDFYCSF-UHFFFAOYSA-N 615200 US20230271945, Compound 120 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615200&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620009 484204493 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310357 COc1ccc(cc1)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C22H23N3O4/c1-29-14-8-6-13(7-9-14)20-16(15-4-2-3-5-17(15)24-20)10-11-19(27)25-21-18(26)12-23-22(21)28/h2-9,18,21,24,26H,10-12H2,1H3,(H,23,28)(H,25,27) JZALZTLCXBIYQS-UHFFFAOYSA-N 50547880 CHEMBL4789274::US20230271945, Compound 121 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50547880 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50547880&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620062 461678220 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310358 COc1ccc(cc1)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C22H23N3O4/c1-29-14-8-6-13(7-9-14)20-16(15-4-2-3-5-17(15)24-20)10-11-19(27)25-21-18(26)12-23-22(21)28/h2-9,18,21,24,26H,10-12H2,1H3,(H,23,28)(H,25,27) JZALZTLCXBIYQS-UHFFFAOYSA-N 50547880 CHEMBL4789274::US20230271945, Compound 121 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50547880 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50547880&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620062 461678220 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310359 Cc1ccc(-c2[nH]c3ccccc3c2CCC(=O)N[C@H]2[C@H](O)CNC2=O)c(F)c1 |r| InChI=1S/C22H22FN3O3/c1-12-6-7-15(16(23)10-12)20-14(13-4-2-3-5-17(13)25-20)8-9-19(28)26-21-18(27)11-24-22(21)29/h2-7,10,18,21,25,27H,8-9,11H2,1H3,(H,24,29)(H,26,28) VMXWHCIZSPDJLW-UHFFFAOYSA-N 615202 US20230271945, Compound 122 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615202&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153079218 484204495 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310360 Cc1ccc(-c2[nH]c3ccccc3c2CCC(=O)N[C@H]2[C@H](O)CNC2=O)c(F)c1 |r| InChI=1S/C22H22FN3O3/c1-12-6-7-15(16(23)10-12)20-14(13-4-2-3-5-17(13)25-20)8-9-19(28)26-21-18(27)11-24-22(21)29/h2-7,10,18,21,25,27H,8-9,11H2,1H3,(H,24,29)(H,26,28) VMXWHCIZSPDJLW-UHFFFAOYSA-N 615202 US20230271945, Compound 122 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615202&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153079218 484204495 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310361 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(cc1)C(F)(F)F |r| InChI=1S/C22H20F3N3O3/c23-22(24,25)13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)27-19)9-10-18(30)28-20-17(29)11-26-21(20)31/h1-8,17,20,27,29H,9-11H2,(H,26,31)(H,28,30) CYCGIODZCQAJGO-UHFFFAOYSA-N 615203 US20230271945, Compound 123 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615203&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961781 484204496 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310362 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(cc1)C(F)(F)F |r| InChI=1S/C22H20F3N3O3/c23-22(24,25)13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)27-19)9-10-18(30)28-20-17(29)11-26-21(20)31/h1-8,17,20,27,29H,9-11H2,(H,26,31)(H,28,30) CYCGIODZCQAJGO-UHFFFAOYSA-N 615203 US20230271945, Compound 123 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615203&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 154961781 484204496 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310363 Cc1ccc(cc1)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C22H23N3O3/c1-13-6-8-14(9-7-13)20-16(15-4-2-3-5-17(15)24-20)10-11-19(27)25-21-18(26)12-23-22(21)28/h2-9,18,21,24,26H,10-12H2,1H3,(H,23,28)(H,25,27) DFRNGRVSGODYLX-UHFFFAOYSA-N 615204 US20230271945, Compound 124 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615204&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147352571 484204497 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310364 Cc1ccc(cc1)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C22H23N3O3/c1-13-6-8-14(9-7-13)20-16(15-4-2-3-5-17(15)24-20)10-11-19(27)25-21-18(26)12-23-22(21)28/h2-9,18,21,24,26H,10-12H2,1H3,(H,23,28)(H,25,27) DFRNGRVSGODYLX-UHFFFAOYSA-N 615204 US20230271945, Compound 124 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615204&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147352571 484204497 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310365 Cc1cc(ccc1F)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C22H22FN3O3/c1-12-10-13(6-8-16(12)23)20-15(14-4-2-3-5-17(14)25-20)7-9-19(28)26-21-18(27)11-24-22(21)29/h2-6,8,10,18,21,25,27H,7,9,11H2,1H3,(H,24,29)(H,26,28) NVJHULOGABHXHK-UHFFFAOYSA-N 615205 US20230271945, Compound 125 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615205&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620129 484204498 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310366 Cc1cc(ccc1F)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C22H22FN3O3/c1-12-10-13(6-8-16(12)23)20-15(14-4-2-3-5-17(14)25-20)7-9-19(28)26-21-18(27)11-24-22(21)29/h2-6,8,10,18,21,25,27H,7,9,11H2,1H3,(H,24,29)(H,26,28) NVJHULOGABHXHK-UHFFFAOYSA-N 615205 US20230271945, Compound 125 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615205&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620129 484204498 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310367 Cc1ccc(cc1F)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C22H22FN3O3/c1-12-6-7-13(10-16(12)23)20-15(14-4-2-3-5-17(14)25-20)8-9-19(28)26-21-18(27)11-24-22(21)29/h2-7,10,18,21,25,27H,8-9,11H2,1H3,(H,24,29)(H,26,28) SEJLRHIQOOCFQG-UHFFFAOYSA-N 615206 US20230271945, Compound 126 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615206&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619982 484204499 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310368 Cc1ccc(cc1F)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| InChI=1S/C22H22FN3O3/c1-12-6-7-13(10-16(12)23)20-15(14-4-2-3-5-17(14)25-20)8-9-19(28)26-21-18(27)11-24-22(21)29/h2-7,10,18,21,25,27H,8-9,11H2,1H3,(H,24,29)(H,26,28) SEJLRHIQOOCFQG-UHFFFAOYSA-N 615206 US20230271945, Compound 126 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615206&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153619982 484204499 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310369 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1cc(F)cc(F)c1 |r| InChI=1S/C21H19F2N3O3/c22-12-7-11(8-13(23)9-12)19-15(14-3-1-2-4-16(14)25-19)5-6-18(28)26-20-17(27)10-24-21(20)29/h1-4,7-9,17,20,25,27H,5-6,10H2,(H,24,29)(H,26,28) URMKLJVIOPGOQQ-UHFFFAOYSA-N 615207 3-[2-(3,5-difluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (127)::US20230271945, Compound 127 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615207&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 152965822 484204500 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310370 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1cc(F)cc(F)c1 |r| InChI=1S/C21H19F2N3O3/c22-12-7-11(8-13(23)9-12)19-15(14-3-1-2-4-16(14)25-19)5-6-18(28)26-20-17(27)10-24-21(20)29/h1-4,7-9,17,20,25,27H,5-6,10H2,(H,24,29)(H,26,28) URMKLJVIOPGOQQ-UHFFFAOYSA-N 615207 3-[2-(3,5-difluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (127)::US20230271945, Compound 127 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615207&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 152965822 484204500 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310371 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(Cl)cc1 |r| InChI=1S/C21H20ClN3O3/c22-13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)24-19)9-10-18(27)25-20-17(26)11-23-21(20)28/h1-8,17,20,24,26H,9-11H2,(H,23,28)(H,25,27) IKVMPJJXVNXRSS-UHFFFAOYSA-N 615208 3-[2-(4-chlorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (128)::US20230271945, Compound 128 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615208&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620051 484204501 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310372 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(Cl)cc1 |r| InChI=1S/C21H20ClN3O3/c22-13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)24-19)9-10-18(27)25-20-17(26)11-23-21(20)28/h1-8,17,20,24,26H,9-11H2,(H,23,28)(H,25,27) IKVMPJJXVNXRSS-UHFFFAOYSA-N 615208 3-[2-(4-chlorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (128)::US20230271945, Compound 128 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615208&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620051 484204501 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310373 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(F)c(F)c1 |r| InChI=1S/C21H19F2N3O3/c22-14-7-5-11(9-15(14)23)19-13(12-3-1-2-4-16(12)25-19)6-8-18(28)26-20-17(27)10-24-21(20)29/h1-5,7,9,17,20,25,27H,6,8,10H2,(H,24,29)(H,26,28) IILLFOPYOPFEFK-UHFFFAOYSA-N 615209 3-[2-(3,4-difluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (129)::US20230271945, Compound 129 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615209&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620081 484204502 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310374 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(F)c(F)c1 |r| InChI=1S/C21H19F2N3O3/c22-14-7-5-11(9-15(14)23)19-13(12-3-1-2-4-16(12)25-19)6-8-18(28)26-20-17(27)10-24-21(20)29/h1-5,7,9,17,20,25,27H,6,8,10H2,(H,24,29)(H,26,28) IILLFOPYOPFEFK-UHFFFAOYSA-N 615209 3-[2-(3,4-difluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (129)::US20230271945, Compound 129 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615209&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620081 484204502 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310375 O[C@@H]1CNC(=O)[C@H]1NC(=O)CSc1c([nH]c2ccccc12)-c1ccc(F)cc1 |r| InChI=1S/C20H18FN3O3S/c21-12-7-5-11(6-8-12)17-19(13-3-1-2-4-14(13)23-17)28-10-16(26)24-18-15(25)9-22-20(18)27/h1-8,15,18,23,25H,9-10H2,(H,22,27)(H,24,26) GZAKGRPHOXGJHS-UHFFFAOYSA-N 615210 2-[[2-(4-fluorophenyl)-1H-indol-3-yl]sulfanyl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]acetamide (130)::US20230271945, Compound 130 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615210&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147734194 484204503 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310376 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(cc1)C(F)F |r| InChI=1S/C22H21F2N3O3/c23-21(24)13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)26-19)9-10-18(29)27-20-17(28)11-25-22(20)30/h1-8,17,20-21,26,28H,9-11H2,(H,25,30)(H,27,29) URYKRFDFZYMIOH-UHFFFAOYSA-N 615211 3-[2-[4-(difluoromethyl)phenyl]-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (131)::US20230271945, Compound 131 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615211&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 152968281 484204504 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310377 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(cc1)C(F)F |r| InChI=1S/C22H21F2N3O3/c23-21(24)13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)26-19)9-10-18(29)27-20-17(28)11-25-22(20)30/h1-8,17,20-21,26,28H,9-11H2,(H,25,30)(H,27,29) URYKRFDFZYMIOH-UHFFFAOYSA-N 615211 3-[2-[4-(difluoromethyl)phenyl]-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (131)::US20230271945, Compound 131 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796866 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615211&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 152968281 484204504 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310378 O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cc(F)cc12)C(F)(F)F)-c1ccccc1 |r| InChI=1S/C22H19F4N3O3/c23-12-8-14-13(6-7-17(31)28-20-16(30)10-27-21(20)32)18(11-4-2-1-3-5-11)29-19(14)15(9-12)22(24,25)26/h1-5,8-9,16,20,29-30H,6-7,10H2,(H,27,32)(H,28,31) UPLIKQBLXGXNNM-UHFFFAOYSA-N 615212 3-[5-fluoro-2-phenyl-7-(trifluoromethyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (132)::US20230271945, Compound 132 Apolipoprotein L1 Homo sapiens 600 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615212&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 153620111 484204505 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310379 O[C@@H]1CNC(=O)[C@@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(F)cc1 |r| InChI=1S/C21H20FN3O3/c22-13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)24-19)9-10-18(27)25-20-17(26)11-23-21(20)28/h1-8,17,20,24,26H,9-11H2,(H,23,28)(H,25,27) CNYZYDUBGMRAFP-UHFFFAOYSA-N 615213 3-[2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3R,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (133)::US20230271945, Compound 133 Apolipoprotein L1 Homo sapiens 3000 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615213&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 149934848 484204506 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310380 O[C@H]1CNC(=O)[C@@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(F)cc1 |r| InChI=1S/C21H20FN3O3/c22-13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)24-19)9-10-18(27)25-20-17(26)11-23-21(20)28/h1-8,17,20,24,26H,9-11H2,(H,23,28)(H,25,27) CNYZYDUBGMRAFP-UHFFFAOYSA-N 615214 3-[2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3R,4S)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (134)::US20230271945, Compound 134 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615214&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 149934847 484204507 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03 1310381 O[C@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(F)cc1 |r| InChI=1S/C21H20FN3O3/c22-13-7-5-12(6-8-13)19-15(14-3-1-2-4-16(14)24-19)9-10-18(27)25-20-17(26)11-23-21(20)28/h1-8,17,20,24,26H,9-11H2,(H,23,28)(H,25,27) CNYZYDUBGMRAFP-UHFFFAOYSA-N 615215 3-[2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4S)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (135)::US20230271945, Compound 135 Apolipoprotein L1 Homo sapiens 52500 US Patent 10.7270/Q2FJ2MXG aid1796865 US9725441 CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F 8/31/2023 10/15/2023 Vertex Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=615215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000800&target=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=615215&enzyme=Apolipoprotein+L1&column=ki&startPg=0&Increment=50&submit=Search 147257821 484204508 1 MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL 7L6K,7LFB,7LFA,7LF7,7LFD Apolipoprotein L1 APOL1_HUMAN O14791 A5PLQ4 B4DU12 E9PF24 O60804 Q5R3P7 Q5R3P8 Q96AB8 Q96PM4 Q9BQ03